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ABSTRACT

Quorum sensing bacteria produce and release chemical signal molecules (like Nacyl homoserine lactones, AHL) that increase in concentration as a function of cell
density. The responses cover a large spectrum of process such as the virulence in
Staphylococcus aureus, competence for DNA-uptake in Bacillus subtilis and
Streptococcus pneumoniae, sporulation in Bacillus subtilis, conjugal plasmid transfer in
Enterococcus faecalis, and bacteriocin production in lactic acid bacteria. The collapse of
(AHL) signaling system in bacteria represents an attractive therapeutic approach towards
the development of new antibiotics.

Recently, a new extracellular modulator was

isolated from a symbiotic bacterium (Bradyrhizobium japonicum) that nodulates soybean.
This quorum sensing molecule, containing a novel oxetane ring, was partially
characterized

and

named

bradyoxetin

(2-{4-[[4-(3-aminooxetan-2-

yl)phenyl](imino)methyl]phenyl}oxetan-3-ylamine). The objective of this dissertation
research was to confirm the absolute stereochemistry of bradyoxetin by total synthesis,
with the production of the four possible stereoisomers. Novel chemical strategies for the
efficient formation of oxetane rings were developed, using the inexpensive chiral drug
chloramphenicol as a starting material. Employing a five-step protocol, suitable oxetane
intermediates were synthesized and characterized as precursors to the final step of
bradyoxetin synthesis.

Approaches towards the synthesis were also developed for the

construction of the natural product oxetin. New scaffolds bearing an oxetane ring were
created for the future development of new antibiotics.
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CHAPTER 1: QUORUM SENSING
1.1 Introduction to Quorum Sensing
There is a global consensus that a part of the microbial world that was once
“under a limited control” is now at the edge of a mass rebellion. The drug arsenal once
used to control diseases caused by pathogenic bacteria genera such as Staphylococcus,
Mycobacterium and Streptococcus have become in many instances useless. Bacteria have
acquired resistance to antibacterial drugs by a variety of mechanisms which include, but
are not limited to, the increased ability to degrade anti-bacterial compounds through βlactamases (Mansour et al., 2008), decreased permeability (Kumar & Schweizer, 2005),
decreased affinity for antibiotics (Zapun et al., 2008), and increased efflux (Xian-Zhi &
Nikaido, 2009) of antibiotics which leaves us with the option of discovering new drugs or
developing new strategies to circumvent the resistance problem.
Cellular communication, whether among nerve cells, or bacteria, happens through
the complex use of signaling molecules that govern basic cellular activities and
coordinating cell actions, representing a reasonable target for drug discovery. In bacteria,
the organization and coordination resembles multi-cellular organisms (Bassler & Losick,
2006; Ben-Jacob & Levine, 2006) and is referred to as “quorum sensing” (Hentzer &
Givskov, 2003). Before a necessary and drastic change in the environment occurs there
must be a minimum concentration of a bacterial population, therefore termed, a quorum.
The size of the population is sensed by the individuals; in this particular case the cells,
through chemical signaling. Therefore, the signals used in bacterial language are small
molecules, sometimes referred as auto-inducers (AIs) (Pomianek & Semmelhack, 2007),

1

or pheromones (Kleerebezem, 1997) released into the environment where they grow
(Figure 1). Examples of such molecules include acyl-homoserine lactones (1-2) (Parsek
and Greenberg 2000), diketopiperazines (3-4) (Holden et al., 1999), quinolones (5) (Pesci
et al., 1999), γ-butyrolactones (6-7) (Chun et al., 1997; Hentzer et al., 2002; Manefield et
al., 2002) and surprisingly a borate (8) (Xin et al., 2002).

Figure 1. Autoinducer chemotypes.

When the concentration of autoinducers reaches a threshold level perceived by the
population, it is said that the population is “quorated” (Telford, 1998), which implies that
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there is a significant number of individuals able to make a behavioral group-base decision
(de Kievit, 2000). The molecules have to travel either from one cell to another to
implicate an effective change; cross the cell surface through active transport (Pestova et
al., 1996) or passive diffusion, and reach a different cell. The signal producing proteins
in Gram-positive bacteria are membrane embedded proteins responsible for a double task,
namely production and secretion of chemical signals (Ishii, 2010). In Gram-negative
bacteria the cytosolic type Lux-I protein has been identified and belongs to the most
common and studied route (Williams, 2007).
Once inside the cell, the signal will have to interact with a receptor which will
convert the chemical signal into information. This “chemical data” will most likely end
up as a “genetic instruction” or expressed gene. Different species tend to use different
sets of molecules for different tasks, but one set of molecules can have antagonistic or
agonistic response in different species of bacteria. In the previously cellular scenario
described above there are places for agonistic and antagonistic events. Both can be used
to elicit a desirable therapeutic response. The interventions can be summarized in seven
categories: i.) inhibition of auto inducer synthesis; ii.) auto inducer receptor antagonism;
iii.) inhibition of targets downstream of receptor binding; iv.) sequestration of auto
inducers by antibodies; v.) degradation of auto inducers performed by either enzymes or
catalytic antibodies (abzymes); vi.) inhibition of auto inducer transport/secretion and;
vii.) antagonism of autoinducer’s receptors.
Although it is widely believed that quorum sensing has an impact on cellular
activity, it is not necessary for bacterial survival per se. It can be very useful as an
adjuvant therapy but quorum sensing molecules lack bactericidal and/or bacteriostatic
3

activity. Quorum sensing been implicated in a wide variety of changes in phenotypes
including: secretion of virulence factors (Dong et al., 2001; Lyon & Muir, 2003; Jones et
al., 2005), biofilm formation (Hentzer et al., 2003; Kaufmann et al., 2006),
bioluminescence production (Dunlap, 1999; Frezza et al., 2007), conjugation (Vannini et
al., 2004), sporulation (Varga, 2004), expression of virulence factors (Harraghy et al.,
2007), swarming motility (Gonzalez Barrios et al., 2006) and symbiosis (Rumbaugh,
2007).
1.2 Quorum Sensing Pathways and Inhibitors
In order to have a better understanding of how quorum sensing can be used to
manipulate bacterial behavior, it is critical to have a better understanding of quorum
sensing pathways. There are three pathways that describe interactions among bacteria: 1.)
the autoinducer peptide (AIP) quorum sensing pathway, 2.) the acyl-homo-serine lactone
(AHL) quorum sensing pathway and 3.) the autoinducer 2 (AI-2) pathway.
The AIP pathway is the most common type of quorum sensing pathway among
Gram-positive bacteria. The chemical signals used are oligopeptides, which are
structurally limited to 5-17 amino acids residues and are usually modified posttranslationally with diverse cyclic structures including thiolactones (9) (Mayville et al.,
1999; McDowell et al., 2001), lanthionine (e.g., nisin or subtilin) (Kies et al., 2003;
Kleerebezem, 2004; Dufour et al., 2007) or isoprenyl groups, as in the case of the unique
ComX pheromone (10) from Bacillus subtilis (Ansaldi et al., 2002). These functionalities
are thought to provide binding selectivity and signal specificity in Gram- positive bacteria
(Figure 2).
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Figure 2. Diverse AIPs: Thiolactones from Streptoccocus aureus, and
isoprenoidal ComX from Bacillus subtillis.

The AIPs start their cycle by binding to a receptor on the bacterial surface which
is part of the two component adaptive system for the detection of autoinducers. These
two component systems are composed of a sensor and a response regulator protein which
utilizes phosphorylation for signal status. If the AIP is bound to a receptor,
phosphorylation of the histidine sensor kinase protein (letter H-Figure 3) occurs. A
second event uses the phosphoryl group of the histidine kinase for the phosphorylation of
a conserved aspartate residue (letter D-Figure 3) of a response regulatory protein. The
response regulatory protein is involved in the synthesis and release on the AIPs, forming
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a feedback loop control and the expression of number of genes which leads to quorum
sensing phenotypic responses. The exporting of the AIPs is performed through active
transport using ATP-binding cassettes (ABCs) which are also responsible for the
processing of the peptide-pheromone precursors (Ishii, 2010). Once transported out of the
cell, the peptide-pheromones can interact with another cell or be used by the same cell
initiating the cycle again.

Figure 3. Model of quorum sensing that involves peptide pheromones and a
two component system in Gram-positive bacteria (Kleerebezem, 1997).
(Permission granted for reproduction).

The other Gram-positive bacteria quorum sensing system have minor, but
important modifications, including the addition of an accessory gene regulatory system
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(Agr) (Peng, 1988). Examples are found in S. aureus and also identified in Agr-like gene
system (AgrF or Fsr) in E. faecalis (Qin et al., 2000). These bacteria still possess protein
histidine kinase (designated as AgrC in S. aureus (Lina et al., 1998) and FsrC in E
.faecalis (Qin et al., 2000) but use different peptide export proteins instead of the ABC
proteins. Additionally, AgrA (Koenig et al., 2004) is the response regulator and AgrD
(McDowell et al., 2001) is the protein responsible for the AIP production. AgrB (Zhang
et al., 2002; Qiu et al., 2005) is the protein responsible for the modification of the peptide
produced by AgrD (Zhang et al., 2004) and secretion of the modified peptide to the
medium (Figure 4).
These two systems have gained extra attention since S. aureus and S. epidermidis
are the main causes of nosocomial infections. It is known that the locus agr is a global
regulatory gene and hence responsible for a number of virulence factors (Ji et al., 1995).
In S. aureus the strains are categorized into four agr subgroups. The expression of each
of these agr genes can inhibit other pathways (Jensen et al., 2008).

7

Figure 4. Structural differences in AgrCs of Staphylococcus aureus (Jensen et
al., 2008) (Permission granted for reproduction).

Based on the pathways described, it is feasible to propose that the inhibition of
key points in the biochemical pathway of quorum sensing could elicit a shutdown of the
system, provoking a desirable therapeutic effect. Select AIP targets may include: i.)
antagonism of AIP receptor; ii.) histidine protein kinase inhibitors; iii.) inhibition of
phosphoryl transferases from the His residue to the Asp residue of the response regulator;
iv.) inhibition of the enzymes responsible for the AIP synthesis and/or post-translational
modification and; v.) inhibition of efflux transporters responsible for AIP effusion across
membrane.
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1.3 Histidine Protein Kinase Inhibitors
Patients with cystic fibrosis are likely to suffer from pulmonary infections. A
common

pathogen

involved

in

such

infections

is

Pseudomonas

aeruginosa

(Roychoudhury et al., 1993) which synthesizes the ex-polysaccaride coat alginate thus
rendering the access of bactericidal drugs to the correspondent site of action a difficult
task. The genes involved in alginate production are part of a two component system
regulated by AlgR2/AlgR1. Histidine kinase AlgR2 is inhibited by compounds 11 and 12
while inhibitor 13 was reported to interfere with the DNA binding activity responsible for
the response regulator AlgR1. Inhibitors 13 and 14 also act on a broader spectrum of
histidine kinases such as CheA, NRII, KinA and VirA (Figure 5).

Figure 5. Histidine protein kinase inhibitors.
A zerumbone analog 15, Figure 6, (Yamamoto et al., 2001) inhibited the histidine
kinase of YycG on Bacillus subtilis (Kitayama et al., 2004). Additional zerumbone
analogs were synthesized (e.g., tryptophan analog 16) and found to be equipotent with 15
(Kitayama et al., 2007). Several analogs also exhibited activity against methicillinresistant S. aureus (MRSA) and vancomycin-resistant E. faecalis (VRE).

9

Figure 6. Zerumbone histidine kinase inhibitors.

1.4 AIP Antagonists
In 1995, it was demonstrated that the virulence factors in S.aureus were controlled
by a cell density system that made use of an octapeptide produced by the bacterium itself.
The study also revealed that this octapeptide activated the expression of the agr locus; the
octapeptide sequence was determined to be YSTCDFIM (Ji et al., 1995). The peptide was
purified, characterized and synthesized but had no detectable activity. Evaluation of the
mass spectrometry data suggested that this synthetic peptide was dimeric and its mass
included a neutral loss of water. When interpreted as a whole, this led the authors to
suggest that the cysteine in the synthetic peptide was oxidized to a disulfide and the
natural isolated pheromone contained a cyclic thioesther introduced post-translationally.
The hypothesis was confirmed by treatment of the native peptides with iodoacetic acid
and hydroxylamine. Iodoacetic acid failed to react with the peptide (as evidenced by no
free SH groups), while hydroxylamine reacted with the putative thioester, yielding a
product that lacked biological activity (Ji et al., 1997).
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Additional insights were acquired through structure-activity relationship studies
with a series of analogs synthesized to determine key residues that are involved in
agonistic or antagonistic activity (Table 1). Conclusions were drawn from these studies
that demonstrated the sulfur atom, when oxidized, abolishes biological activity. Also
when the methionine was replaced with norleucine, serine, glutamic acid, lysine or
proline, no activity was observed (McDowell et al., 2001).
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Comp.

R1

R2

R3

R4

R5

R6

IC50

AIP-1

H-Tyr-Ser-Thr

CH2CH2SCH3

Asp

Phe

Ile

S

-

19 nM

H-Tyr-Ser-Thr

CH2CH2SOCH3

Asp

Phe

Ile

S

-

-

CH3CO

CH2CH2SCH3

Asp

Phe

Ile

S

8 µM

-

Gly-Val-Asn-Ala

CH2(C6H5)

Ser

Ser

Leu

S

2 nM

-

CH3CO

CH2(C6H5)

Ser

Ser

Leu

S

4 µΜ

-

H-Tyr-Ser-Thr

CH2CH2SCH3

Asp

Phe

Ile

NH

-

24 µΜ

H-Ala-Ser-Thr

CH2CH2SCH3

Asp

Phe

Ile

S

-

161 nM

H-Tyr-Ala-Thr

CH2CH2SCH3

Asp

Phe

Ile

S

-

9 nM

H-Tyr-Ser-Ala

CH2CH2SCH3

Asp

Phe

Ile

S

-

248 nM

H-Tyr-Ser-Thr

CH2CH2SCH3

Ala

Phe

Ile

S

33 nM

H-Tyr-Ser-Thr

CH2CH2SCH3

Asp

Ala

Ile

S

-

9 µΜ

H-Tyr-Ser-Thr

CH2CH2SCH3

Asp

Phe

Ala

S

-

11 µΜ

H-Tyr-Ser-Thr

CH3

Asp

Phe

Ile

S

-

9.5 µΜ

AIP-II

ED50

-

Table 1. Structures and activities of diverse AIPs.

The most compelling changes were achieved when alanine was introduced in the
place of aspartic acid on the cyclic structure, which changed the nature of the peptide
from an activator, with ED50 of 19 nM, to an inhibitor of toxic shock syndrome toxin
(TTST-1) and enterotoxin C-3, with an IC50 of 33 nM.

D-Amino

acids were also part of

the study and analogs of AIP-1 replacing the L-amino acid residue for the D-isomer were
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tested. In the case of activation, the activity was reduced for most of the analogs with the
exception of D-Phe and D-Met.
An SAR study performed with AIPs revealed that for S. aureus, a common
template was able to antagonize AgrC: TrAIP-II (Mayville et al., 1999). The SAR study
revealed important details about the interaction between the peptides produced by AgrD
and the receptor AgrC such as: (i) the amino acid sequence and the stereochemistry of the
AIP are critical for the interaction between the peptide and its receptor; (ii) inhibition of
agr expression is undermined if either the amino acid sequence or stereochemistry is
altered, but not when the changes concern the chemical reactivity of the cyclic linkage.
The synthesis of the peptides used in the SAR study was performed using solid-phase
protocols.

Figure 7. Synthesis of S. aureus AIPs (Mayville et al., 1999)
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The study also proposed that AIPs of the same S. aureus class bind differently
from AIPs of different S. aureus types. On an intraclass association, side chain
interactions would increase the specificity leading to an adjustment that would position
the thiol ester linkage of the peptide next to a nucleophilic group embedded on AgrC.
Therefore a covalent bond between AgrC and the the AIP would be formed, imparting
conformational changes on the receptor resulting in the histidine kinase to suffer transphosphorylation through dimerization (Cisar et al., 2009). The aforementioned events
would lead to the activation scenario and therefore to signal-transduction and expression
of agr.

Regarding the interclass receptor-ligand scenario, there would not be a

nucleophilic attack due to the non-aligment provided by the absent side-chain
interactions. Therefore a non-covalent binding interaction would take place and no
signal-transduction would be possible leading to the antagonistic thread (Figure 8).
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Figure 8. Proposed model for agonism and antagonism of AgrC (Mayville et al.,
1999). (Figure reproduced with permission).

It was hypothesized that the peptide side chain (sometimes referred as the tail)
bound to the thiolactone has a fundamental role for the activation of the AgrC receptorhistidine kinase, as well as for defining the agonistic/antagonistic nature of the AIP. With
this in mind, a second SAR study was conducted involving chimeric receptors and
diverse AIPs (wild and synthetic) from a variety of Staphylococcus species. The test of
the chimeric receptors against a number of AIP analogs localized the primary ligand
recognition site to the receptor distal subdomain and revealed that the AIPs bind
primarily to a putative hydrophobic pocket in the receptor (Figure 9). This interaction is
driven in part by a highly hydrophobic moiety on the AIPs which proved to be essential
for self- activation as well as for cross-inhibition (Wright et al., 2004).
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Figure 9. Strategy used to generate chimeric AgrC and alignment of wild
AIPs from different Staphiloccocci showing the highly conserved amino acids
9 and 8 as well as the cysteine residue (Wright et al., 2004). (Figure
reproduced with permission).

The study determined several intrinsic aspects of the AIP-AgrC interaction: i.) the
distal region of the AgrC domain contains the primary elements involved for activation;
ii.) the specificity for the activation in the AIP can be accounted to D5 and Y5 (Figure 9)
on AIP-I and AIP-IV, respectively, in the macrocycle ring adjoining the conserved
cysteine; iii.) the proximal domain of the receptor confers a secondary role in ligand
cross-reactivity presenting the ability to react to noncognate AIPs; iv.) a massive
hydrophobic residue, conserved on all Staphylococcus AIPs seems to be a key component
for AgrC-AIP binding.
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The ligand-binding event of AgrC-AIP is expected to generate conformational
changes in the AIP and/or the AgrC receptor for activation. It is also important to note
that the chimeric receptors can be of critical importance in the study of interactions
between ligand and receptor (Figure 10).

Figure 10: activation and inhibition of AgrC. The binding is driven by the
hydrophobic patch (two circles) into the hydrophobic binding pocket (shaded in
yellow). (Wright et al., 2004). (Figure reproduced with permission)

An interesting SAR study was recently reported, in which 10 analogs of trAIP-II
(17) were synthesized (George et al., 2008).

Since compounds lacking the side chain

would present an inhibitory effect, they were tested against AgrC-II to investigate the
cognate effects and against AgrC-I for the non-cognate effects. The following
conclusions were made based on the study: (i) regarding cognate and non-cognate
inhibitory effect, both groups have similar tendencies; (ii) from the compounds that have
measurable activities it was observed that the antagonism for the non-cognate receptor
(AgrC-I) was stronger than of the cognate-receptor (AgrC-II); (iii) a main pharmacophore
group for agr antagonism in trAIP-II was improved. One half of the molecule including
17

cysteine and two terminal hydrophobic residues are critical for activity. The remainder of
the molecule seems to be non-essential as shown in Figure 11.

Figure 11. Proposed pharmacophore model for trAIP-II.

Other AgrC antagonists were discovered in a unique SAR study involving AIP1(18) and AIP-2 (19). Some issues were considered in designing the features for AgrC
antagonists: (i) two amino acids in the macrocycle are essential for the interactions of
AIP-1 and AIP-2 with their respective cognate receptors, Phe6Ile7 (in AIP-1) and
Leu8Phe9 (in AIP-2); (ii) the substitution of the aminoacid vicinal to the highly conserved
cysteine (Asp5 for AIP-1 and Ser6 for AIP-2) for an Ala residue resulted in a powerful
AgrC competitive antagonist (Mayville et al. 1999; McDowell et al., 2001; Lyon et al.,
2002). Indeed, (Ala5)AIP-1 (Figure 12) is a potent inhibitor on all S. aureus AgrCs with
IC50 values ranging between 0.3 and 21 nM; (iii) analogs lacking the exocyclic tail are
weak antagonists although the exocyclic tail seems to have an impact on the macrocyclic
“address” affinity.

1

H-NMR studies were performed on the (Asp5) AIP-1 analog. The

hydroxy belonging to Ser2 and Thr3 revealed a doublet at δ 4.95 and a triplet at δ 5.24
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while the hydroxyls for AIP-1 revealed two broad singlets. This implied that the hydroxy
groups in (Asp5)AIP-1 are solvent shielded with a very slow rate of exchange. Therefore
it was proposed that a substitution of Asp5 for an Ala residue would provoke minor
changes in the macrocyclic conformation but would induce critical adjustments in the
exocyclic tail culminating in an affinity increase (Chan et al., 2004).

Figure 12. AIP-1 and (Ala5)AIP-1.

Based on (Ala5)AIP-1 an additional set of analogs were synthesized and
evaluated. The replacement of Asp5 by Ala did not affect activity. The replacement of
Tyr1 by biphenyl moieties had an impact on the affinity for AgrC-1, but not for AgrC-2.
Biostability is always an issue when one considers drug design strategies
(Grabley, 1999). With this in mind, N-substituted glycines oligomers, or peptoids, have
been shown to be valuable peptide mimetics due to their high stability and relative ease
of synthesis (Patch, 2004). Additionally, many biologic phenomena have been reported to
be probed by peptoids (Hara et al., 2006; Xiao et al., 2007).
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Peptomers (peptide-peptoid hybrids) (Østergaard & Holm, 1997) were proposed
as feasible mimetics for AIP-1, following the logic of previous SAR works (Fowler et al.,
2008). A series of peptomers were tested and it was discovered that one of them was able
to stimulate bio-film formation, presenting an agonistic role in S. aureus quorum sensing
(Figure 13).
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Figure 13. Peptomer with biofilm stimulatory activity on S. aureus.

Recently antibodies were used as AIP antagonists (Park et al., 2007). Initial focus
centered on the AIP-4 QS system and its cognate strains RN4850 and NRS168 (Lyon et
al., 2000). The hapten AP-4 (21) was designed with a major concern in mind,
replacement of the native thiolactone for a lactone-containing hapten in order to improve
aminolytic stability (Shigenaga & Janda 2006). This strategy prevented any structural
change during the immunization process therefore averting the production of compounds
generated due to degradation haptens (Kaufmann et al., 2005), as well as a possible intra
molecular thiol exchange. The antibody was obtained through the immunization of mice
after synthetic AP4-hapten 5 (22) was conjugated with carrier proteins keyhole
hemocyanin (KHL) and bovine serum albumin (BSA) (Figure 14).
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Figure 14. Structures of AIP-4 and AIP-4 hapten-5.

Twenty monoclonal antibodies (mAbs) were prepared and one of them, AP24H11, had a strong binding affinity for AIP-4 (Kd

AIP-4

= 90 nM) when compared to

other AIPs (Kd AIP-1 = 5 mM, Kd AIP-2 = 25 mM, Kd AIP-3 = 25 mM). AP-24H11 showed an
impressive aptitude to discriminate AIP-1 from AIP-4 (the difference between them one
aminoacid, an aspartic acid residue for AIP-1 on position 5 instead of a tyrosine residue
for AIP-4). This high level of recognition led the authors to a further investigation of
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mAb AP4-24H11 which reduced the expression of α-hemolysin and increased the
production of protein A in the strains of group IV, RN4850 and NRS168. Such results
are consistent with the hypothesis that mAb AP4-24H11 is able to modulate the quorum
sensing in S. aureus of group IV. The pathogenicity of S. aureus in an in vivo abscess
formation mouse model could also be suppressed showing that mAbs are feasible tools to
suppress QS associated with S. aureus virulence.

1.5 AHL Quorum Sensing Pathway
A large number of Gram-positive bacteria uses AHL (acyl homoserine lactone) as
signaling molecules in their quorum sensing system. The AHLs consist of a fatty acyl
chain that is linked to a lactone (generated from an homoserine) through an amide bond.
The AHLs possess a significant chemical diversity among bacteria. Even the same
bacteria can synthesize different types of AHLs. The structural divergences are focused
on the size and composition of their acyl chain.
Usually the length of the chains has been reported to range between 4 to 16
carbons. The chains may have double bonds which can vary from increments of two
carbon units as in C4, C6 and C8. The third carbon in the chain can be a carbonyl or
simply bear a hydroxy, or in the simplest case, be fully reduced to an alkyl carbon. The
diversity on the third position occurs merely in the biosynthetic process (Figure 15). In
the case of Pseudomonas aeruginosa for example FabG is responsible for the reduction
of the carbonyl of C-3 in acetoacetyl-ACP to d-3-hydroxybutyryl-ACP (Hoang et al.,
2002).
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Figure 15. Biosynthesis of homoserine lactones in Pseudomonas aeruginosa.
The quorum sensing in Gram-negative is regulated by a large number of
regulatory proteins. Among them the Lux-R proteins are the most studied. Most of the
Lux-R family of proteins are transcriptional activators responsive to AHL, although the
repressors also exist in nature (Swift et al., 1997). Table 2 illustrates the AHL diversity,
in addition to the bacteria, signal, regulators, and the expressed phenotype.
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Entry

Bacterium

1

Aeromonas
hydrophila

2

Aeromonas
salmonicida

3

Agrobacterium
tumefaciens

4

Burkholderia
cenocepacia

AHL structure

Designation

LuxI/R

QS phenotype

BHL, C4

Ahy/AhyR

Exoprotease
production

BHL, C4

AsaI/AsaR

Extracellular
prorease

OOHL
3-oxo-C8

TraI/TraR

conjugal transfer
of the Ti plasmid

Crown gall
tumor; large
growths on
plant host

HHL, C6

CepI/CepR

Biofilm,
swarming
motility,
virulence

Opportunistic
human
pathogen;
common
infection in
CF patients;
may cause
disease in
plants

OHL, C8

PmlI1/Pml
R1

Virulence,
exoprotease

3-hydroxy-C8

PmlI2/Bpm
R2

Melioidosis,
affects lungs,
heart, brain,
liver, kidneys,
commonly
found in
Southeast Asia

HHL, C6

CviI/CviR

Exoenzymes,
cyanide, pigment

Rare human
pathogen, can
cause skin
lesions and
sepsis

OHHL,
3-oxo-C6

ExpI/ExpR
CarI/CarR

Carbapenem,
exoenzymes,
virulence

Plant
pathogen;
Common
cause of decay
in stored fruits
and vegetables

OHHL,
3-oxo-C6

ExpI/ExpR

Pectate lyases

OHHL,
3-oxo-C6

EsaI/EsaR

Exopolysaccharide,
virulence
factors

OHHL,
3-oxo-C6

LuxI/LuxR

bioluminescence
symbiosis

OHL, C8

AinS/AinR

bioluminescence
symbiosis

HHL, C6

PhzI/PhzR

Phenazine
antibiotics

Target or
Effect on
host

(Swift et al., 1997)

(Swift et al., 1997)

(Zhang et al., 2002)

(Lewenza et al., 1999)
OHL, C8
(Sokol et al., 2003)
5

Burkholderia
pseudomallei

(Kiratisin and Sanmee 2008)

(Ulrich et al., 2004)
6

Chromobacterium
violaceum

7

Erwinia
caratovora

(McClean et al., 1997)

(Welch et al., 2000;
Burr et al., 2006)
8

Erwinia
chrysanthemi

9

Erwinia stewartii

10

Photobacterium
fischeri
(Vibrio fischeri)

(Castang et al., 2006)

(von Bodman et al., 1998)

(Schaefer et al., 1996)

(Gilson et al., 1995;
Lupp & Ruby 2004)
11

Pseudomonas
aureofaciens

(Zhang & Pierson 2001)
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Luminescent
bacterium
found in light
organs of
monocentrid
fish and
sepolid squid

12

Pseudomonas
aeruginosa

alkaline protease,
elastase, cyanide
(HCN)
production,
hemolysin,
exotoxin A,
neuraminidase,
pyocyanin and
rhamnolipid
production

Oportunistic
pathogen; one
of the major
causes of
hospital
acquired
infections
(urinary tract,
burn, external
ear)

PpuI/PpuR

Biofilms

Saprophytic
soil bacterium;
bioremediatio
n of
naphthalene
contaminated
soils

CinI/CinR
RhiI/RhiR
RaiI/RaiR
TraR
BisR

Root nodulation,
Symbiosis,
plasmid transfer,
Growth inhibition

Symbiotic
nitrogen fixing
bacterium to
legumes (e.g.
peas)

7-cis-C14-HSL

CerI/CerR

Dispersal from
bacterial
aggregates

BHL, C4

SwrI/SwrR

Extracellular
protease,
swarming

SinI/SinR
ExpR
TraR

Nodulation and
symbiosis

OdDHL,
3-oxo-C12

LasI/LasR
QscR

BHL, C4

RhlI/RhlR

OdDHL,
3-oxo-C12

(Smith et al., 2002)

(Smith & Iglewski, 2003)
13

Pseudomonas
putida

ODHL,
3-oxo-C10
(Steidle et al., 2002)
14

Rhizobium
leguminosarum

3-Hydroxy-7cis-C14
(Schripsema et al., 1996;
Yajima et al., 2008)
HHL, C6

(Gray et al., 1996)
15

Rhodobacter
sphaeroides

16

Serratia
liquefaciens

(Puskas et al., 1997)

HHL, C6
(Eberl et al., 1996)
17

Sinorhizobium
meliloti

DDHL, C12

Symbiotic
nitrogen fixing
bacterium to
legumes (e.g.
alfafa)

3-oxo-9-cis-C16

9-cis-C16:1
(Marketon et al., 2002)
18

Vibrio
anguillarum

terminal
hemorrhagic
septicemia
known
as vibriosis in
fish

OdDHL,
3-oxo-C12

VanI/VanR

3-hydroxy-C4HSL

LuxLM/
LuxN

Bioluminescence

OOHL
3-oxo-C8

YpsR/YpsI

Regulation of
clumping and
motility

(Milton et al., 1997)
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Vibrio harveyi

20

Yersinia pseudotuberculosis

(Cao & Meighen, 1989)
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HHL, C6

YtbR/YtbI

ODHL,
3-oxo-C10

YspI/YspR

OHHL,
3-oxo-C6

Ype/YpeR

(Atkinson et al., 1999)
21

Yersinia pestis

Regulation of
clumping and
motility

(Kirwan et al., 2006)

Table 2. AHLs, bacteria, and receptors associated with their quorum sensing.
Phenotype regulated by the QS and effect on the host.

It is interesting to note the immense variety of bacteria that use quorum sensing
involving AHLs. The historically relevant species, Yersinia pestis, was responsible for a
number of epidemic episodes including The Plague of Justinian in 542 A.D. and the
Black Death, which occurred from 1347 to 1353 A.D. and wiped out at least one third of
the European population.

More important is to realize that many of these bacteria

produce the exact same chemical signal, but use them for different functions. For
example OHHL is produced by Vibrio fischeri and by Yersinia pestis; two completely
different bacteria regarding pathogenicity, yet they are able to provide distinct phenotypic
response when in contact with a certain concentration of OHHL.
The LuxR type proteins, which are the receptors of the acyl-HSL, can be
subdivided in two domains. The first one contains the binding site which is located near
the N-terminal of the protein. Mutations on that site proved to extinguish the binding of
3-oxo-C6-HSL to LuxR (Hanzelka, 1995). Further studies proved that it is also possible
to block the effects of cognate autoinducers, generating per se an antagonic response
(Schaefer et al., 1996). The second domain, containing the C-terminus, has a helix-turnhelix (HTH) motif, which is required for DNA binding. When the binding between the
acyl-HSL and the N-terminal domain occurs it leads to a series of conformational
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changes that culminate in multimerization of the complex LuxR type protein-acyl-HSL
and further DNA binding.
A greater insight of the binding mechanism was acquired with the crystallization of
TraR (a close homolog of LuxR from Agrobacterium tumefaciens) with its cognate ligand
(3-oxo-C8-HSL) and a oligonucleotide, as depicted in Figure 16 (Zhang et al., 2002).

Figure 16. Binding site of 3-oxo-C-HSL after dimerization. (Figure reproduced
with permission).

In the case of TrA, after its cognate ligand binds to its site in the N-terminal
region, it forms a dimer, with each monomer being composed of two folded domains
attached by a flexible linker region. This domain forms an α-β-α sandwich that
coordinates ligand interactions through the central β sheet. The central β-sheet has five
anti-parallel strands and is curved, with the 3-oxo-C8-HSL bound to its concave surface.
The pheromone is fully surrounded by the protein and has no significant contact with
solvent. Hydrophobic and aromatic residues comprise most of the 3-oxo-C8-HSL binding
pocket. The acyl chain runs parallel to a β-sheet surface and is surrounded by lipophilic
side chains in the protein.
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The fact that the ligand is completely surrounded by the protein draws a distinction
from the typical concept of ligand-receptor in which the receptors hold the ligand-binding
site exposed. That indicates that the actual “receptor” for 3-oxo-C-HSL in
Agrobacterium tumefaciens is the “nascent” unfolded form of TraR (Zhu & Winans,
2001).
After the dimer is formed and the “nascent conformation is changed”, the complex
binds to DNA through the HTH motif. Transcriptional activation of the associated
promoter follows the binding of the lux type box.

1.6 Inhibitors of AHL Synthesis
Biofilms, in particular, have received special attention since their formation
protects bacteria from treatment with antibiotics as well as from the host immune system.
The treatment of bacterial infections where a biofilm is present represents a challenge in
therapeutic settings. Concerning this matter, autoinducer analogs were synthesized and
tested against Pseudomonas aeruginosa. Several proved to be efficient in reducing both
virulence factors and biofilm formation (Figure 17) demonstrating that small template
molecules based on quorum sensing can provide a new insight to the generation of
antibacterial agents (Smith et al., 2003).
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Figure 17. Inhibition of biofilm formation by autoinducers analogs on
Pseudomonas aeruginosa. (Figure reproduced with permission.

The design and synthesis of artificial AHLs proved to be strong inhibitors of the
production of virulence factors, which are necessary for pathogenesis (Geske et al.,
2007). This also corroborates the fact that small molecules involved in quorum sensing
can serve as templates for the development of new antibacterial agents.
Therefore, the identification of synthetic small molecules that can play either an
antagonist or agonist role in the quorum sensing process represents a valid pursuit in the
design and development of new antibiotics.
The next section will describe methods for the construction of oxetane rings,
based on the recent identification of a new QS molecule, bradyoxetin (23; Figure 18).

Figure 18. Structure of bradyoxetin.
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CHAPTER 2: OXETANE RING SYNTHESIS
2.1 Introduction to oxetanes
Oxetanes are defined as four member ring cyclic ethers. This functional group is
present in a number of pharmacologically relevant and complex natural products
including the antitumor agent paclitaxel (24), the antiviral agent oxetanocin (25), and the
endogenous antiplatelet agent thromboxane A2 (26).

Figure 19. Pharmacologically relevant molecules containing an oxetane ring.

A number of other “less celebrated” natural products containing the oxetane ring
have been isolated from nature (Figure 20) including mitrephorone A (27; Li et al.,
2005), (+)-(Z)-laureatin (28; Irie et al., 1968; Irie et al., 1970; Kurosawa et al., 1973),
dictyoxetane (29), merrilactone (30) and one of the simplest oxetanes, oxetin (31).
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Figure 20. Additional natural products containing an oxetane ring.

2.1 Synthesis of oxetanes: Intramolecular cyclization reactions
The most common way to synthesize an oxetane ring is through the use of an
intramolecular 4-exo-tet-displacement reaction. This strategy has been used for the
incorporation of constrained oxetane rings as in the synthesis of the the natural product
paclitaxel and into carbohydrate backbones (Christensen, 2003). Studies have shown that
the 4-exo-pathway most often is the preferable way to proceed with the cyclization
instead of the chemically permitted 5-exo and 3-exo cyclizations. The leaving groups are
commonly mesyl (Brennan et al., 2004), tosyl (Holton et al., 2002; Isaacs et al., 2002)
and halogens (Uttaro et al., 2005). Scheme 1 depicts the 4-exo-tet transformation in the
synthesis of the oxetane ring of paclitaxel analogs, using precursors 32 or 33 for the
construction of 34.
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Scheme 1. Formation of oxetane rings via 4-exo-tet displacement reactions.

In total synthesis of isomeric laureantins, a 4-exo-tet-displacement was used to
install the oxetane ring (Scheme 2). The beauty with this strategy lied in the formation of
a key substrate (35) that would serve a double task, namely, for the installment of a furan
ring in intermediate (36), ultimately used for (+)-3-(Z)-isolaureatin production, and for
oxetane ring formation (compound 37), for (+)-3-(Z)-laureatin synthesis (Kim et al.,
2007).

Scheme 2. Synthesis of laureantin and isolaureatin precursors utilizing 4exo-tet-displacement reactions.

Oxetane rings were also produced in studies involving the synthesis of
gymnomitrane terpenoids (Scheme 3).

Treatment of tosylated 38 with bulky non-
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nucleophilic bases led to the formation of oxetane 39 and ring-expanded product 40,
formed as a result of a Grob fragmentation reaction (Toyota et al., 2000).

Scheme 3. Oxetane ring synthesis vs. Grob fragmentation.

In an attempt to synthesize oxetin (31) analogs (Jenkinson et al., 2004), an
approach based on the use of chiral pool

D-xylose

was examined (Scheme 4). The

oxetane ring was constructed through a ring contraction of α-triflate-γ-lactone (41) with
K2CO3 in methanol at low temperature, affording bicyclic oxetane 42.

Scheme 4. Synthesis of oxetanes through ring contraction of α-triflate-γ-lactones.
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The bicyclic oxetane 42 was submitted to three separate reaction types to reveal
its utility as a useful building block (Scheme 5). Deprotection of the acetonide afforded
diol 43, while treatment with triethylsilane and trifluoroacetic acid led to the selective
formation of secondary alcohol 44 (DeNinno et al., 1995).

Finally, a bromination

reaction using Hanessian-Hullar conditions with N-bromosuccinamide afforded 45
(Hullar & Siskin 2002).

Scheme 5. Generation of oxetane building blocks.

Oxetane 44 was further submitted to a series of protection and SN2 displacement
reactions that ultimately led to the production of azido oxetanes 45 and 46, suitable latent
amine precursors for future drug discovery efforts (Figure 21) (Jenkinson et al., 2004).

Figure 21. Azido oxetanes as latent amine precursors.

34

The formation of oxetane 48 from a polycyclic system 47 revealed a very
uncommon displacement reaction on a tertiary center (Khan et al., 2005). The conjugate
addition of an alkoxide to an alkynoate 49 was also used for the formation of oxetane 50
(Scheme 6) (Wendling & Miesch 2001).

Scheme 6. Uncommon oxetane ring synthesis reactions.

35

2.2 Synthesis of oxetanes: Electrophilic cyclization reactions
Oxetanes can also be formed through electrophilic cyclization reactions of
unsaturated alcohols. One of the first examples reported invoked the addition of NBS to
a δ-hydroxy vinylsilane 51 derived from adamantanone (Scheme 6). The product was a
curious adamantane spirooxetane 52 (Ehlinger & Magnus 1980).

Scheme 7. Synthesis of oxetanes through electrophilic cyclization reactions.

Similar transformations were performed with vinylsilanes to investigate
mechanistic issues in the cyclization reaction. For example, vinylsilane homoallylic
alcohols 53 and 54 furnished spirooxetanes 55 and 56, respectively, when treated with
bis(syn-collidine) bromine(I) hexafluoroantimonite (Rofoo et al., 2001). When the
hydroxy group occupied a secondary carbon or, conversely, the proton β to the hydroxy
group was substituted with a methyl group, diastereoselectivity was not preserved.
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Scheme 8. Synthesis of oxetanes using bis-collidine complexes.

The electrophilic cyclization reaction of homoallylic alcohols using NBS has also
provided a powerful method for generating molecules suitable for X-ray crystal
diffraction studies and absolute configuration determination (Scheme 8). For example,
treatment of 57 with NBS afforded the bromo-oxetane 58 (Manabe et al., 1985), while
reaction of 59 with NBS yielded the dibromo-oxetane 60 (Paquette et al. ,1999).

Scheme 9. Reaction of homoallylic alcohols with NBS.
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These reaction types are not limited to the use of NBS. In fact, the reactive
reagent N-iodosuccinimide (NIS) was also employed in the synthesis of neoclerodane
diterpenoids containing an oxetane moiety 62 from its respective homoallylic alcohol 61
(Scheme 9) (de la Torre et al., 2000).

Scheme 10. NIS mediated oxetane synthesis.
Endo-Norborneols containing tertiary hydroxy groups (e.g., 63) have been
reported to react with phenylsulfonyl chloride and n-BuLi providing oxetanes (e.g., 64)
and hence generating an intricate oxatricyclo[3.2.1.03,6]octane (Scheme 9) (Brown &
Fallis 1985).

Scheme 11. Synthesis of a tricyclic oxetane from endo-Norborneols.
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Further studies involving norbornenes were conducted with the aim of
investigating the regio- and stereoselectivity of electrophilic addition reactions using
phenylselenyl chloride and phenylsulphonyl chloride (Scheme 10). The formation of the
oxetane occurred with substrates bearing an endo-hydroxy group (65 to 66); as
anticipated, exo-hydroxy substrates 67 failed to produce the oxetane product, but rather,
formed the standard olefin addition product 68. (Arjona et al.,1987; Arjona et al., 1989;
Arjona et al., 1992).

Scheme 12. Stereochemical requirements for oxetane ring synthesis.

Electrophilic cyclization reactions were employed utilizing homoallylic alcohols
(69-71) and [I(collidine)2+]ClO4- complexes, generating three to seven member ring
iodoethers, including oxetanes (72-74), which were produced in satisfactory yields
(Scheme 11) (Evans, 1988).
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Scheme 13. Synthesis of iodo-oxetanes with [I(collidine)2+]ClO4-.

Electrophile-mediated cyclization reactions of homoallylic alcohols possessing an
ester group were also scrutinized. The reaction was prone to form oxetanes in addition to
tetrahydrofurans in the presence of iodine and acetonitrile. When silver triflate was
added the process suffered a significant acceleration. Generally the cyclizations have
presented good stereocontrol for both oxetanes and tetrahydrofurans (Galatsis et al. 1994;
Galatsis & Parks 1994; Galatsis et al., 1997). Replacement of the ester with the Evans
chiral auxiliary (75) afforded oxetane products (76-77) with a good diastereoselectivity
(Scheme 12)
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Scheme 14. Evans chiral auxiliary-directed oxetane synthesis.

An interesting report concerning the synthesis of a [2.2.0] fused ketal 81 was
disclosed (Wang et al., 1999), prepared from the initial Mitsunobu inversion reaction of
78 in the formation of β-lactone 79 (Scheme 13). This product was carried through
several reactions, ultimately leading to the production of compound 80, subsequently
transformed into ketal 81 using an electrophilic cyclization reaction (Dollinger et al.,
1999).

Scheme 15. Synthesis of a [2.2.0] oxetane (ketal).
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Other examples involving electrophylic cyclizations for the synthesis of oxetanes
include the use of NIS in DCM (Barks et al., 1994), I(coll)2ClO4 in DCM for the
production of oxetane-dimethanols as oxetanocins analogs (Jung & Nichols 1996), and
the use of silver(I)oxide (Alonso, 2000) and mercuric triflate (Imagawa, 1998) as
electrophilic reagents.

2.3 Synthesis of oxetanes: Cationic cyclization reactions
Cationic cyclization reactions have been used to promote oxetane formation
(Craig et al., 1999). Thiopyridyl acetals containing a silyl enol ether (82-83) proceed
through intramolecular reactions promoted by silver (I) to provide cis-[3.2.0] substituted
oxetanes (84-85) bearing an exo-acyl group (Scheme 14).

Scheme 16. Cationic cyclization reactions of thiopyridyl acetals.
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The cyclization reactions were conducted with pure diastereomer substrates in
order to gain mechanistic insight. A model to explain the cyclizations was proposed in
which the oxetane ketone substituent is placed exo- on the bicyclic system. The silyl enol
ether was not reactive using these cyclization conditions. The reaction proved to be
consistent with the existence of an intermediate carbenium ion (Figure 22).

OTBDMS
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TBDMSO

t-Bu
H

O
H

t-Bu
O

O

Figure 22. Cationic intermediates in cyclization reactions.
Similar reaction conditions were employed using carbohydrate substrates, since
more highly oxygenated systems could have impaired the stability/lifetime of the
anomeric cations (Scheme 15). The same authors provided a similar example where the
generated cation is stabilized by an exocyclic thioether.

Scheme 17. Carbohydrate substrates in cationic cyclization reactions.
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2.4 Synthesis of oxetanes: Rearrangment of epoxides
Azo-epoxides 88 can undergo photochemical fragmentation to provide oxetanes
(e.g. 89) through a 1,2-shift of the C-O bond in the intermediate diradical (Scheme 16)
(Abe et al., 2002).
Ph
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h
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Scheme 18. Photofragmentation of azo-epoxides to produce oxetanes.

trans-2,3-Epoxycyclooctanol (90) reaction with DAST provided the expected
epoxy fluoride 91 as well as a 2-fluorooxetane (92) (Scheme 17). The explanation for the
formation of 92 is based on the classic Wagner-Meerwein shift (Lakshmipathi et al.,
2002).

Scheme 19. Synthesis of oxetanes through epoxide rearrangements.

Chiral hydroxyoxetanes (94) are produced as a result of an intramolecular 4-exocyclization reaction when benzyl or propargyl ether tethered epoxides (93) and mixed
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alkyllithium and/or metal alkoxide superbases like LIDAKOR are used (Scheme 18)
(Mordini et al., 2001).

Scheme 20. Synthesis of oxetanes via cyclization reactions of epoxy ethers.

3,4-Epoxyalcohols can suffer isomerization under acidic or basic conditions, as
observed in the synthesis of dictyoxetane (Proemmel et al. 2002), first isolated from the
known brown algae Dictyota dichotoma (Pullaiah et al., 1985) (Rao et al., 1986).

The

same observations were exploited in the final step of merrilactone synthesis (Birman &
Danishefsky 2002; Inoue et al., 2006; He et al., 2007; Inoue et al., 2007). The literature
refers to this rearrangement as an acid-induced homo-Payne rearrangement (Scheme 19).
A similar acid-promoted tandem rearrangement-cyclization reaction was observed in
epoxyalcohols containing benzyl ethers (Mosimann, 2000).

Scheme 21. Homo-Payne rearrangement in the synthesis of merrilactone.
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During the synthesis of phytuberin, it was found that diol 98 [generated from the
starting material (-)-α-santonin (97)] treated with methanesulfonic acid, proceeded
through an uncommon 4-endo-tet cyclization, generating an unexpected oxetane 99
(Scheme 20) (Prange et al., 2003).

Scheme 22. Formation of oxetanes through 4-endo-tet-cyclization.
In the first total synthesis of laureatin (Sugimoto et al., 2007), the authors
exploited a biogenetic pathway in an attempt to convert an oxocene to bicyclic skeletons
by using a bromo-cationic cyclization reaction. Unfortunately, undesirable cyclization
reactions forced the group to seek an alternative route that would provide the laureatin
skeleton.

The successful pathway exploited a 4-exo-tet cyclization reaction of the

epoxyalcohol 100 with KOH in DMSO at 80oC affording oxetane 101 (Scheme 21).
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Scheme 23. Synthesis of laureatin precursors via epoxyalcohol rearrangements.
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An unusual oxetane ring formation reaction was reported in attempts to prepare
paclitaxel using model substrates; a transannular cyclization and rearrangement occurred
when epoxide 102 (Scheme 22) was treated with KOH in DMSO, leading to the
formation of oxetane 103 (Johnston et al. 1998).

Scheme 24.Oxetane synthesis through an α-ketol ring contraction.

2.5 Synthesis of oxetanes: 4-endo cyclization reactions
The formation of oxetanes through 4-endo-cyclizations is uncommon. The
examples reported in the literature utilize allylic alcohols as substrates and
bis(collidine)bromine(I) hexafluorophosphate (Homsi & Rousseau 1998). Cinnamic
alcohols 104 or 105 produce the same trans-substituted oxetane 106, implying cationic
intermediates (Scheme 23).
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Scheme 25. Example of a 4-endo cyclization reaction.

Studies on reaction of bicyclo[4.4.0] bridgehead alcohols 107 with NBS also
suggests a 4-endo cyclization reaction, with the formation of dibromo-oxetane 108
(Scheme 24) (Wempe & Grunwell 1995).

Scheme 26. Synthesis of a dibromo-oxetane.
.
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CHAPTER 3: RESULTS AND DISCUSSION
3.1 Introduction
Our initial efforts are directed towards the total synthesis of the unique quorum
sensing molecule bradyoxetin (23), in an attempt to confirm its absolute configuration
and to explore opportunities for analog synthesis (Figure 23). A total synthesis of the
four possible stereoisomers and comparison with the data from the natural product would
confirm its structure. To date, there are no reported syntheses of bradyoxetin.

Figure 23. Bradyoxetin and oxetin structures.
Our first approaches towards the synthesis of bradyoxetin were based on the first
total synthesis of (2R,3S)-3-aminooxetane-2-carboxylic acid (31, oxetin), an amino acid
oxetane isolated from Streptomyces sp. OM-2317 (Omura et al., 1984). Its absolute
configuration was determined by X-ray crystallography and later confirmed by total
synthesis (Kawahata et al., 1986). The first reported and rather cumbersome synthesis of
31 began with aldehyde 109, synthesized in several steps from D-glucose (Scheme 25).
Reaction of 109 with the appropriate phosphorane using standard HWE conditions
afforded a mixture isomeric esters, separable by silica gel chromatography. The reduction
of the esters with DIBAL-H furnished Z- and E-allylic alcohols (110 and 111
respectively) as shown in Scheme 25.
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Scheme 27. Initial steps of the D-glucose pathway for oxetin synthesis.
Independent reactions of 110 and 111 with m-CPBA afforded a mixture of four
diastereomeric epoxides (112-115). The epoxides were separated using standard
chromatographic techniques, and subsequently were converted to azido-oxetanes (116119) in three steps following a procedure previously reported (Scheme 26) (Behrens,
1983).
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Scheme 28. Azido-oxetanes derived from chiral epoxides.
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Each azido-oxetane (116-119) was converted to an oxetin isomer through a sixstep sequence that involved: i.) hydrogenation (10% Pd/C) to convert the azide to the
amine group; ii.) protection of the amine with a CBz group; iii.) deprotection of the
acetonide auxillary with 0.1 N H2SO4 to furnish 1,2 deprotected furanosides; iv.)
reduction with sodium borohydride; v.) oxidation with sodium periodate and RuCl3; vi.)
CBz group deprotection. This yielded four pure stereoisomers, of which, the oxetane
product derived from 116 matched with the naturally occurring product, and its structure
was confirmed as (2R,3S)-3-aminooxetane-2-carboxylic acid (31) (Scheme 27).

Scheme 29. Synthesis of oxetin and its stereoisomers.

3.2 First Synthetic Approach to Bradyoxetin
Based on the synthesis reported for oxetin, a retrosynthetic approach was
formulated (Scheme 28) where the key features invoked the use of an appropriate
aldehyde A in either a Wittig reaction for the generation of E-cinnamic esters, or
conversely, a Horner-Wadsworth-Emmons (HWE) reaction for the generation of the Zcinnamic esters. Standard DIBAL-H reduction of the α,β-unsaturated esters followed by
a Sharpless epoxidation reaction of the resulting allylic alcohols would lead to chiral
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epoxides (B).

The epoxide stereoisomers would then be converted in independent

reactions to the mono-tosylated amine (C) for the creation of oxetanes (D). To produce
the symmetrical imine we envisioned using cobalt octacarbonyl catalysts to generate a
ketone (Enquist et al., 2003) subsequent conversion to the hydroxylamine (Ulbrich et al.,
2006) and finally, to the requisite product 23 (Akazome et al., 1990).

Scheme 30. First retrosynthetic approach to bradyoxetin.

Our first synthetic approach began with a simple Wittig reaction between 4iodobenzaldehyde (123) and (carbethoxymethylene)triphenylphosphorane (124) which
yielded the E-ester 125 as the predominant product (Scheme 29) (Couladouros & Soufli
1995). The ester obtained from this reaction contained a minor amount of the Z-isomer
which was not separated at this stage. Ester 125 was reduced to the allylic alcohol 126
with DIBAL-H (Boger et al., 1994). This product was submitted to a Sharpless
asymmetric epoxidation yielding ((2S,3S)-3-(4-iodophenyl)oxiran-2-yl)methanol (127)
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using titanium isopropoxide, (+) L-diisopropyltartrate and t-butylhydroperoxide (Boger et
al., 1994).

Scheme 31. Synthesis of chiral epoxide 127 from 4-iodobenzaldehyde.
The Katsuki-Sharpless asymmetric epoxidation (Katsuki & Sharpless 1980)
opened a new spectrum of possibilities in the context of chiral synthesis of compounds
with relevant biological activity. It has been extensively applied to reactions of 2,3epoxyalcohols with a variety of nucleophiles (Hanson, 1991). It is noteworthy that the
synthetic utility of these intermediates is highly dependent on the regioselectivity of the
addition reaction. The majority of epoxides are reactive towards metal azides or even
organoazides, such as Me3SiN3. In order to improve their reactivity, the addition of
catalysts to the reaction are usually employed. Common catalysts include ammonium
salts (Bonini et al., 1995; Schneider, 2000), AlCl3 (Fringuelli et al., 2001) and copper(II)
salts (Fringuelli et al., 2003). The regioselectivity of azidolysis is very similar to that of
other nucleophiles. To summarize, monoalkyl epoxides suffer nucleophilic attack by
azides preferentially at the terminal methylene group where styrene-based epoxides suffer
attack on the benzylic carbon.
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The epoxide 127 was subsequently reacted with sodium azide in methanol in
order to generate the required 1,3-diol 128 (Scheme 30). Unfortunately, analysis of the
azide addition product by 1H-NMR and 13C-NMR techniques was ambiguous to assign of
the location of the azide group. A very simple and efficient way to differentiate 1,2-diols
from 1,3-diols lies not on spectroscopic methods, but on organic chemistry. 1,2-diols,
when treated with HIO4 produce aldehydes which would be very easy to detect. On the
contrary 1,3-diols do not cleave when reacted with HIO4 (Smith, 2007). Treatment of the
azide addition product with HIO4 led to the formation of an aldehyde product (IR
analysis), which suggested that the azide addition product corresponded to structure 129.

Scheme 32. Reaction of epoxide 127 with sodium azide and subsequent reactions.
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Further confirmation of the azide addition product was realized when azido-1,2diol 129 was then reacted with tosyl chloride, dibutyltin oxide and triethylamine in
anhydrous DCM to afford mono-tosylated derivative 130 (Martinelli et al., 1999),
confirmed by analysis of the 1H- and

13

C-NMR spectra. Azido tosylate 130 was

submitted to basic conditions (potassium tert-butoxide) to provide a mixture of three
compounds, 131-133. Compound 133 proved to be an epoxide due to its distinct shifts in
the 1H- and

13

C-NMR spectra. The spectroscopic data obtained for compounds 131 and

132 were diagnostic for isomeric olefins, which led us to the conclusion that epoxide 133
generated was subject to additional chemical reactions, namely, elimination reactions
(Scheme 33).

Scheme 33. Proposed mechanism for the formation of elimination products.

Overall, the picture was clear: nucleophilic attack of azide on epoxide 127 leads
to the production of azido-diol 129, being governed by the inductive effect of the
aromatic ring.

In order to produce the correct azide regioisomer, we chose to install a

carbonyl pendant to the epoxide ring. The generation of epoxy carboxylic acid 134
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(Scheme 32), would shift the postition of the nucleophilic attack and provide the desired
regioisomer 135 (Boger et al., 1994).

Scheme 34. Proposed installment of a carbonyl group.
In order to capitalize on using carboxylic acid epoxides (e.g., 134) epoxide 127
required an oxidation. Three oxidation reactions were attempted and included the use of
ruthenium chloride and sodium periodate (Denis, et al. 1986), pyridinium dichromate in
DMF (Boger, et al. 1994) and periodic acid and chromium oxide (Zhao, et al. 1998).
None of the synthetic methodologies provided the desired carboxylic acid epoxide 134.
It is noteworthy that Boger applied similar chemical strategy in the total synthesis of
bouvardin, O-methyl bouvardin and O-methyl-N9-desmethylbouvardin. In his reported
syntheses, three distinct methods for the generation of 1,3-diols bearing a 4-iodophenyl
moiety were also examined: treatment of an epoxy ester with aqueous methylamine,
reaction of the epoxyalcohol with isocyanate and further hydrolysis of carbamates with
introduction of an azide using a Sharpless asymmetric dihydroxylation

(Boger &

Yohannes 1991). Boger’s approach using a Sharpless dihydroxylation was considered,
but not applied due to the high price of the chiral auxiliary used in the reaction.
An alternative solution to the problem surfaced, with the realization that chelating
agents such as trimethylborate can be used to direct nucleophilc attack (Sasaki et al.,
2003). The chelation effect is evident when comparing reactions that use ammonium
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chloride as a catalyst.

In the trimethylborate-directed reaction (Scheme 33),

complexation of the borate to the pendant hydroxy group of epoxy alcohol 136 polarizes
the non-substituted carbon and makes it more reactive as an electrophile, leading to
azido-1,3-diol products 137. When this reaction was performed on 127, the anticipated
azido-1,3-diol 128 was not formed, but rather, the azido 1,2-diol 129. It appears that
coordination between boron and oxygen was not suitable to overcome the effect provided
by the presence of the aromatic ring which prompted us to seek an alternative strategy.

Scheme 35. Use of chelation control in epoxide ring opening reactions.
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3.3. Second Synthetic Approach to Bradyoxetin
Our second approach relied on the direct synthesis of oxteanes from allylic
alcohols (Scheme 34). Several precedents guided this approach: the reactions of allylic
alcohols with halogenated collidine complexes to generate oxetanes (Homsi & Rousseau
1999) and the possibility of conducting SN2 reactions on oxetanes with the retention of
configuration (Jenkinson et al., 2004; Johnson et al., 2004).

Scheme 36. Collidine complexes for the synthesis of oxetanes.

Bis(collidine)bromine(I) hexafluorophosphate (140) was formed from the reaction
between bromine and bis(collidine)silver(I) hexafluorophosphate (139) (Clausen & Bols
2000). The silver(I) complex 139 was generated from the reaction of collidine (138),
silver nitrate and potassium hexafluorophosphate in water (Homsi et al., 2000). The
reaction of 140 and allylic alcohol 126 afforded a low-yielding mixture of bromo58

oxetanes 141. Although the yields were dismal, this reaction represented the first
successful synthesis of oxetanes whose structures were confirmed by 1H NMR and

13

C

NMR. Preliminary studies invoking substitution reactions with azide and 141 failed to
yield substitution products. The drawbacks of this approach were the low yield of
oxetane products, the failure of replacing the halogen with an azide group through SN2
reaction, and the lack of asymmetric control in the synthesis.

This approach was

abandoned in favor of a more robust synthesis.
3.4. Third Synthetic Approach towards Bradyoxetin
The third approach takes advantage of the stereochemical features inherent in the
natural product chloramphenicol (142) a broad spectrum antibiotic that was first isolated
from Streptomyces venezuelae in 1947 (Scheme 35) (Ehrlich et al., 1947).

We

envisioned that 142 could be transformed into differentially substituted oxetanes 143 and
144, suitable for a metal-mediated coupling en route to the synthesis of bradyoxetin (23).

Scheme 37. Chloramphenicol approach for bradyoxetin synthesis.
The advantages of using chloramphenicol as a starting material are twofold: 1.)
it is inexpensive and commercially available, and 2.) it is a chiral starting material whose
regiochemical configuration is already defined for the formation of aminooxetanes.
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Furthermore, both enantiomers of choramphenicol and its amide hydrolysis product are
commercially available.
The main challenge at hand was to choose a reasonable protecting group strategy.
The azide group was selected, insofar as it would serve as a latent protecting group for an
amine during the construction of amino-oxetanes. Carbamate protecting groups pendant
to an oxetane ring (e.g., 145), suffer a rearrangement during its attempted removal with
trifluoroacetic acid, leading to oxazolidines 146 (Scheme 36) (Bach & Schröder 1997;
Bach & Schroder 1999). Azides possess multiple advantages over other amine protecting
groups, the most obvious residing its chemical stability to a wide variety of reaction
conditions (Nyffeler et al., 2002).

Scheme 38. Rearrangments of N-Boc oxetanes in the presence of TFA.

In order to employ an azide as a protecting group, the amine functionality in
chloramphenicol had to be transformed to the azide.

A robust method for this

transformation is the diazotransfer reaction (Nyffeler et al., 2002). There are two types of
diazotransfer reactions described in the literature. The most common is referred to as a
Regitz diazotransfer reaction (Regitz, 1967) which involves the transfer of a diazo group
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from a tosyl- or mesyl-azide to an active methylene group. The methylene group can be
a part of a 1,3-diketone and the reaction demands the use of a base such as Et3N in order
to proceed with the formation of an enolate (Scheme 37).

Scheme 39. Regitz diazotransfer reaction.

The second type of diazotransfer reaction converts an amino group into an azide,
using triflic anhydride and sodium azide (triflic azide).

Either aliphatic or aromatic

amines (Liu & Tor 2003; Yan et al., 2005) can be transformed into azide groups,
affording an amino surrogate which in turn, can be easily reduced to amines that have
their configuration retained (Fischer & Anselme 1967; Cavender & Shiner 1972; Vasella
et al., 1991). The change of solvent and addition of transition metal salts (e.g., Cu(II))
have increased the efficiency of this reaction (Alper et al., 1996). Although not obvious,
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the reagents used in this reaction are extremely safe (previous reactions using
dichloromethane (DCM) and sodium azide can be dangerous, with the formation of
unstable diazidomethane (Conrow & Dean 2008).
The mechanism for this reaction still remains to be confirmed, although a
dianionic tetrazene has been proposed as one of the key intermediates (Scheme 40)
(Fischer & Anselme 1967; Nyffeler et al., 2002).
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Scheme 40. Proposed mechanism of diazotransfer reaction.

More recently a new methodology for the diazotransfer reaction has been
developed with the synthesis of an efficient, inexpensive and shelf stable reagent,
imidazole-1-sulfonylazide hydrochloride (147) (Scheme 41) (Goddard-Borger & Stick
2007).
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Scheme 41. Synthesis of imidazole-1-sulfonyl azide hydrochloride (147).

Synthetic approach 3 began with the hydrolysis of chloramphenicol (142)
(Rebstock et al., 1949) with aqueous NaOH, which afforded the amino 1,3-diol product
148 in modest yields (Scheme 42). The amine was converted to the azide 149 through the
use of triflic azide (generated in situ with triflic anhydride and sodium azide in anhydrous
acetonitrile), copper sulfate and triethylamine in anhydrous acetonitrile. The product was
selectively tosylated at the primary hydroxyl group with dibutyltin oxide and tosyl
chloride (Martinelli et al., 1999), affording tosyl azide 150.
OH

OH
OH

O2N

HN
142

Cl
Cl
O

NaOH 0.1N
66%
O2N

OH

NH2
148

OH Tf 2O, NaN3
CuSO4, Et3N
87%
O2N

OH
N3
149
TsCl, EtN3
Bu2SnO
85%
OH
O

O2N

N3
150

Scheme 42. Synthesis of azido alcohols using chloramphenicol precursors.
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The tosyl azide 150 was reacted with potassium tert-butoxide, a standard reagent
used for oxetane ring synthesis from precursor 3-hydroxy-1-tosylates. However, repeated
attempts to form 151 from 150 resulted in the production of intractable mixtures of
compounds. Examination of the literature revealed that the nitroaromatic ring could
suffer vicarious nucleophilic substitutions when treated with potassium tert-butoxide to
yield products carrying substituents on the para and/or ortho positions (Krylova et al.,
2001); (Makosza & Podraza 2000); (Stalewski, 1998); (Makosza & Kwast 1998);
(Makosza & Sienkiewicz 1998). This effect appeared to be limited to the nucleophilic
tert-butoxide, so in an attempt to obviate this problem, we utilized several nonnucleophilic bases. Reactions performed with 150 in the presence of NaH or DBU failed
to yield the desired oxetane 151 (Scheme 43). Therefore another strategy was conceived
in order to avoid the undesired reactions that were provoked by the nitro substituent in
the aromatic ring.

Scheme 43. Attempted synthesis of oxetanes from azido tosylate precursors.

A logical choice was to reduce the nitro group to an amine after the diazotransfer
reaction, and then make use of Sandmeyer reaction to manipulate the substituents in our
favor. In other words, the reduction would have to be selective to aromatic nitro groups
leaving the aliphatic azide intact. Several methods for selective reductions were
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attempted, employing sodium bisulfite or sodium sulfide reducing systems (Park et al.
1993; Brouillette et al., 2003; Huber et al., 1988). Using literature conditions, reduction
of 149 provided the desired aniline product 152, in low yields, perhaps due to the
difficulty associated with purification and product stability (Scheme 44).

Scheme 44. Selective reduction of nitroaromatics to anilines.
Since these reduction reactions were not effective, a modified approach was
adopted, where the diazotransfer reaction would be applied to a molecule with two amino
groups, hence the nitro group would need to be reduced at the beginning of the synthesis.

Scheme 45. Selective diazotransfer reaction.
Treatment of the chloramphenicol hydrolysis product 148 under standard
hydrogenation conditions (Pd/C; H2; EtOH) yielded the aniline 153 (Scheme 45). The
diazotransfer reaction was conducted on 153 using 1.1 equivalents of triflic azide
(prepared in situ from triflic anhydride and sodium azide) in the presence of copper
sulfate and triethylamine, resulting in the formation of aliphatic azide 152 in excellent
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yield. To our surprise, the aliphatic amine has a preference over the aromatic amine
regarding the diazotransfer reaction. Therefore it was possible, using the correct ratio
between amino substrate and triflic azide, to selectively transform only the aliphatic
amine into the azide, while sparing the aromatic amine. Additionally, the use of excess
triflic azide results in the formation of the bis-azide product 154 (Scheme 46).

Scheme 46. Formation of bis-azide 154 from diazotransfer reaction of 153.

The success of the diazotransfer reaction then set the stage for a Sandmeyer
reaction, where the aromatic amine in compound 152 would be converted to a bromide
(155), iodide (156), and a nitrile (157) (Scheme 47). We used initially a variant of the
Sandmeyer reaction, which employs a halodimethylsufonium halide formed in situ from a
hydrohaloic acid and DMSO (in our case HBr) (Baik et al., 2005). This methodology
proved beneficial, although the yields were not superior to the traditional Sandmeyer; the
major drawback involved the product work-up protocols.
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Scheme 47. Sandmeyer reactions of 152.
The use of the Sandmeyer reaction to produce both halogenated (Boojamra, 2003)
and aromatic nitriles (Bühler et al., 2004) was conducted in order to take advantage of
these functional groups in later coupling reactions. The Sandmeyer products (155-157)
were characterized by MS evaluation and 1H and 13C-NMR spectroscopic analysis.

Scheme 48. Synthesis of (2R,3R)-3-azido-2-(4-bromophenyl)oxetane (159).
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The bromo-azide derivative (155) was then subjected to a selective tosylation
reaction under standard condtions yielding tosyl azide 158; treatment with potassium tertbutoxide afforded (2R,3R)-3-azido-2-(4-bromophenyl)oxetane (159) in modest yields;
159 was reduced using Staudinger protocol followed by its conversion to an oxalate 199
(Scheme 48). The same set of reaction schemes were used for the synthesis of 4((2R,3R)-3-azidooxetan-2-yl)benzonitrile (161) from tosyl azide 160; later reduction of
161 using Staudinger conditions yielded 4-((2R,3R)-3-aminooxetan-2-yl)benzonitrile; the
amino oxetane 196 was then converted in an oxalate salt (Scheme 49). The same set of
reactions were employed for the synthesis of (2R,3R)-3-azido-2-(4-azidophenyl)oxetane
(163), derived from tosyl azide 162 (Scheme 50).

Scheme 49. Synthesis of 4-((2R,3R)-3-azidooxetan-2-yl)benzonitrile (161) and 4((2R,3R)-3-aminooxetan-2-yl)benzonitrile (196).
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Scheme 50. Synthesis of (2R,3R)-3-azido-2-(4-azidophenyl)oxetane (163).

The use of potassium tert-butoxide in the cyclization reaction afforded low
product yields due principally to competing reactions, in particular, elimination reactions.
In an attempt to improve the yield of oxetane products in the cyclization reaction, a series
of bases were treated with 162 to optimize the product yields. The use of KN(TMS)2
(Toyota et al., 2000), n-BuLi (Ito, 1997), LDA (Saphier et al., 2004), KH (Sasaki et al.,
1995), and KH (oil free)/18-crown-6 (Tino, 1987), and Cs2CO3 in DMF (Ameijde &
Liskamp, 2003) failed to improve the yield of the oxetane product. Many of the reactions
were performed in temperatures ranging from -78 oC to room temperature. It was later
discovered that potassium carbonate (methanol solvent) was reported to function as an
effective base in promoting 5-exo-tet-cyclization reactions, documented in the synthesis
of the tetrahydrofuran-based natural product Jaspine B (Prasad & Chandrakumar 2007).
Athough carbonate itself is not strong enough to abstract a proton from an alcohol, it has
been documented that potassium carbonate and methanol generates substantial
concentrations of CH3OK in situ (Platonov et al. 2002). Treatment of 162 with potassium
carbonate in methanol afforded a smooth conversion to the oxetane product 163 without
the formation of elimination products. The disadvantage of this reaction is the slow rates
of conversion; on average, reactions were completed in 5 days.
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The successful synthesis of oxetanes derived from the chloramphenicol hydrolysis
product prompted us to prepare the enantiomeric series of 159 and 161. This was easily
accomplished, since the requisite starting material (164) was commercially available.
Scheme 49 depicts the five-step protocol for the synthesis of (2S,3S)-3-azido-2-(4bromophenyl)oxetane (169). Also following the same procedure depicted on Scheme 46,
the formation of the bis azide 166 was accomplished (Scheme 51). The overall yield of
169 was 13.5% from 164.

Scheme 51. Formation of bis-azide 166 from diazotransfer reaction of 165.

Scheme 52. Synthesis of (2S,3S)-3-azido-2-(4-bromophenyl)oxetane (170).
In a similar fashion, the nitrile Sandmeyer product 171 was converted to 4((2S,3S)-3-azidooxetan-2-yl)benzonitrile (173) (Scheme 53). Final oxetane products and
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intermediates were characterized by 1H and

13

C-NMR analysis.

Optical rotation data

also confirmed that stereochemical integrity was preserved through the synthesis.

Scheme 53. Synthesis of 4-((2S,3S)-3-azidooxetan-2-yl)benzonitrile (173).
Mitsunobu reactions were employed as a means to invert the configuration of the
carbon bearing the hydroxy group. This allowed for the expedient synthesis of the
diastereomeric series of compounds. Briefly, 4-bromophenyl- and 4-cyanophenyltosyl
azides (169 and 172 respectively) were treated with DIAD, triphenylphosphine and pnitrobenzoic acid. This afforded p-nitrophenyl esters 174 and 176. Reaction of these
esters with potassium carbonate in methanol afforded the oxetane products directly (via
the initial ester hydrolysis and subsequent cyclization, Scheme 54). The products were
characterized as (2R,3S)-3-azido-2-(4-bromophenyl)oxetane (175) and 4-((2R,3S)-3azidooxetan-2-yl)benzonitrile (177).
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Scheme 54. Mitsunobu reactions in the synthesis of 175 and 177.

With the successful construction of oxetanes with defined stereochemical
conformation and requisite functional groups, the next step was considered. It was
envisioned that a Grignard reaction could be conducted by the reaction of magnesium
with arylbromide 159 and subsequent reaction with nitrile 161, leading to bradyoxetin
precursor with defined stereochemical configuration about the oxetane ring (Scheme 55).
If successful, this reaction would be applied to the other stereoisomeric sets of
arylbromides and arylnitriles precursor oxetanes.
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Scheme 55. Grignard reaction for bradyoxetin synthesis.
Consideration was given to the notion that the azide group may not be compatible
under Grignard reaction conditions. However, several examples were identified in the
literature which suggested otherwise (Scheme 56).
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Scheme 56. Grignard reactions of organomagesium reagents to molecules containing
an azide group.

Reaction of oxetane 159 with magnesium in anhydrous THF was first investigated
on a small scale to determine whether magnesium would insert and form a stable reagent
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(e.g., 178) to add to nitrile 161 and form the imine product (Fergus et al., 2004). Aliquots
of the reaction mixture were taken at various time points, and quenched with dilute acid
(Scheme 57). If the magnesium insertion was successful, (2R,3R)-3-azido-2phenyloxetane (179) would have been produced. Unfortunately, this product was not
identified in the reaction mixture.
O

O

O

Mg, THF
N3

Br

H+
N3

BrMg

X

N3
179

178

159

Scheme 57. Attempts at forming Grignard reagent 178.
Since the insertion of magnesium was not occurring, it seemed appropriate to look
for a more robust method in the literature. An elegant solution was to catalyze the
Grignard reaction with lithium salts, like LiCl. For example, reaction of 4-bromoanisole
with i-PrMgCl (without additive) affords the magnesium insertion product in 18% yield,
but the same reaction in the presence of the additive LiCl, the magnesium insertion
product yield increases to 84% . The reaction is believed to proceed with the formation of
a complex, i-PrMgCl-LiCl, which later catalyzes the Br/Mg exchange reaction (Scheme
58) (Krasovskiy & Knochel 2004).
Cl
Mg Mg

Cl
2 LiCl

Mg Li

Cl

Cl

Cl
2 ArBr
-2 i-PrBr

2 Ar Mg Li
Cl

Scheme 58. Catalysis of the Br/Mg exchange reaction with LiCl.
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A solution of i-PrMgCl-LiCl complex (generated in situ by the addition of a
solution of i-PrMgCl in THF to LiCl) was prepared, and a solution of (2R,3R)-3-azido-2(4-bromophenyl)oxetane (159) was added dropwise and stirred at room temperature for 6
hours. Confirmation of the Mg insertion was established by quenching an aliquot of the
reaction mixture with NH4Cl, which yielded the “naked” phenyloxetane 179 (Scheme
59).

Scheme 59. Successful Mg insertion reactions using LiCl additives.
Once the magnesium insertion reaction was confirmed, the reaction was applied
towards the synthesis of bradyoxetin, as depicted earlier in Scheme 55. However, no
products were formed as a result of Grignard addition to the nitrile (recovered starting
material). This reaction was repeated under a variety of conditions, with changes in
solvent, temperature, and reaction time.

3.5 Approaches towards the synthesis of oxetin
The lack of success in the final stages of bradyoxetin synthesis prompted us to
examine approaches for the synthesis of other oxetane, namely, the oxetin series of
compounds. This approach was based on the fact that aromatic rings can serve as
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carboxylic acids precursors via oxidative degradation reactions in the presence of
ruthenium salts (Scheme 60).

We believed that a number of our “bradyoxetin”

intermediates could be used for the direct synthesis of oxetin stereoisomers.

Scheme 60. Retrosynthetic strategy for the synthesis of oxetin (stereochemistry not
defined).

Oxidative degradation of aromatic rings with ruthenium salts produce carboxylic
acids with overall retention of configuration. Some examples that have successfully been
employed in the oxidative conversion of aromatic rings to carboxylic acids are depicted
in Scheme 61.

Scheme 61. Application of oxidative degradation reactions.
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The RuCl3 oxidizing system has been used successfully with a variety of aryl
substrates including: 2-chloroquinoline (Cho et al., 2004), p-methoxybenzene (Burke &
Voight 2000), 3,4-dimethoxybenzene (Kalvin & Woodard 1985), 2,5-dimethoxybenzene
(Sarma & Chattopadhyay 1982), and acetylated anilines (Wu & Mosher 1986). Not all
aromatic groups are suitable for degradation with Ru catalysts.
The mechanism of the oxidative decarboxylation reaction is illustrated in Figure
24. The first step for the initial cleavage of the aromatic double bond has been
extensively documented. The Ru(VIII) is generated in situ by using a catalytic amount of
RuCl3 and NaIO4 (generally added in a large quantity when compared to the
stoichiometry). The Ru(VIII) is therefore constantly regenerated. The first product of the
oxidation is the α−ketoaldehyde (A) which is subsequentially converted to the aldehyde
hydrate (B) in aqueous media. The hydrate (B) is further oxidized to the keto acid (C),
and undergoes a second hydration reaction leading to intermediate (D). Reaction with
Ru(VIII) species leads to the obligatory pentacyclic ruthenium intermediate (E).
Breakdown of this complex produces the product carboxylic acid (F) and loss of carbon
dioxide (Bruckner, 2010).
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Figure 24: Proposed mechanism for oxidative cleavage of aromatic
compounds with RuCl3 and NaIO4.

Similar oxidative degradation reactions have been reported for the synthesis of
oxetane carboxylic acids (181), formed from the reaction of 180 with RuCl3/NaIO4 in
CH3CN/ethyl acetate/H2O (Scheme 61) (Albert et al., 2001).

Scheme 62. Oxidative cleavage reaction of a 2-phenyl oxetane derivative.
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Initially, we focused our attention to oxetanes that we produced as intermediates
for the total synthesis of bradyoxetin.

The first oxetane selected for the oxidative

cleavage reaction was was (2R,3R)-3-azido-2-(4-azidophenyl)oxetane (163) (Scheme 63),
since it was a side-product formed from a large scale diazotransfer reaction.

Scheme 63. Oxidative cleavage of oxetane 163.

The result of the oxidative cleavage reaction was unusual, insofar as the only
product isolated from the reaction mixture was 4-azidobenzoic acid (182). The oxidation
reaction cleaved the oxetane ring rather than the aromatic ring. A survey of the literature
shed light regarding this unusual oxidation; it appears that certain functional groups
located on the aromatic ring are not suitable for oxidative degradation reactions. A pilot
reaction with compound 152 (Scheme 64) was performed, by initially acetylating both
the amino and hydroxyl substituent, affording 183. This acetylated derivative was
submitted to the oxidative cleavage reaction using RuCl3/NaIO4. In this example, the
oxidative cleavage reaction was successful, clearly substantiating the influence of
functional group effects on the aromatic ring.
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Scheme 64. Oxidative cleavage reaction of 182 with RuCl3 and NaIO4.
The next logical step was to convert the 4-azido oxetane 163 into the 4-amino
oxetane 185 by catalytic hydrogenation (Scheme 65).

Monitoring of the reaction

progress by TLC and MS evaluation suggested that 185 was being formed during the
hydrogenation reaction. However, attempts at isolating 185 from the reaction mixture
failed; a black intractable material was formed upon repeated attempts, possibly due to
the 4-amino groups participation in oxetane ring opening reactions.

Scheme 65. Attempted reduction of bis-azide 163.
A second option for the production of oxetin stereoisomers using the oxidative
cleavage reaction invoked the use of oxetanes bearing an unsubstituted aromatic ring. To
our favor, the amino diol lacking functionality on the aromatic ring (compound 186) had
become commercially available for the first time. Compound 185 was subjected to the
same set of reaction protocols that we developed for bradyoxetin intermediates (Scheme
65). Briefly, a diazotransfer reaction afforded 186, selective tosylation yielded 187, and
cyclization with potassium carbonate in methanol generated (2R,3R)-2-phenyloxetan-380

amine (187) (the same compound produced during our investigation of the magnesium
insertion reaction with arylbromide oxetane 159). Cyclization reactions of 188 using
potassium tert-butoxide failed to produce oxetane 179, and instead, afforded elimination
products.

Scheme 66. Synthesis of (2R,3R)-2-phenyloxetan-3-amine (179).

Reaction protocols were repeated for the synthesis of the remaining isomers of 2phenyloxetan-3-amine (190, 193, and 195) (Scheme 67). Since Mitsunobu reaction
conditions require the use of triphenylphosphine (188 to 189 and 190 to 194), it was
imperative that the PPh3 was completely reacted with the DIAD reagent, since PPh3
reacts with azides in the Staudinger reaction to form iminophosphoranes (Solsona et al.,
2003).
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Scheme 67. Synthesis of chiral 2-phenyloxetan-3-amines.
2-phenyloxetan-3-azides 179 and 195 were submitted to oxidative cleavage
reactions using RuCl3/NaIO4 in acetonitrile/water (Scheme 68).

The only product

isolated from the reaction mixture was benzoic acid.
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Scheme 68. Oxidative cleavage reactions of 2-phenyloxetan-3-amines.
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3.6 Conclusions
This research describes the evolution on the understanding of some of the quorum
sensing pathways and how some of chemical signals can, in different species, trigger
different phenotypic responses. The objectives were tailored to synthetic chemistry
approaches, with the purpose of elucidating the absolute configuration of bradyoxetin.
Regarding conclusions concerning the stereochemistry of bradyoxetin, further
experiments are required, but several insights into the possible relative configuration of
the structures can be inferred. The reported coupling constants obtained from evaluation
of the 1H NMR spectrum between H1 and H2 of bradyoxetin is 2.95 Hz (Loh et. al.,
2002) while the coupling constants for the same set of protons in compound 196 is 6.8
Hz. It appears that the imine bridge between the aromatic rings exerts a larger influence
on the protons H1 and H2 than anticipated. The azido oxetanes do not differ to a large
extent when comparing the coupling constants from the amino oxetanes. The difference
between 161 and 196 was only 0.1 Hz. The synthesized oxetanes offer a better model for
the evaluation than the oxetanes described in the seminal article. They possess a closer
structure than the ones obtained through Paterno-Buchi, which lack a para-substituent and
possess an amide rather than an amine or an azide; their coupling constants are on the
order of 7Hz. Trans-substituted oxetanes possess smaller coupling constants when
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compared to cis-substituted analogs; the values are still large compared to bradyoxetin.

Figure 25. Oxetanes and their coupling constants
Some new insights into oxetane synthesis have been achieved and a new option
has been disclosed for using chloramphenicol and its derivatives as chiral building
blocks. Approaches were also developed for the synthesis of the natural product oxetin,
using aromatic rings as carboxylic acids surrogates with retention of configuration.
Although the completion of both bradyoxetin and oxetin was not achieved, an efficient
route for the synthesis of oxetin has proposed and nearly accomplished, and a new
synthesis of bradyoxetin has been proposed and its total synthesis is on the horizon. It has
been also determined that aliphatic amines are more prone to diazotransfer than aromatic
amines. The inverse was also tested, with aromatic azides being selectively reduced in the
presence of aliphatic azides.
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The future of this research can surely be expanded with the investigation of 2phenyl-3-amino oxetanes as CNS agents, since they share a striking resemblance with
katinone, methamphetamine and other derivatives such as bupropion. The methylation of
the amine can be achieved by following a protocole described in the literature (Sayyed &
Sudalai, 2004).
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Figure 26. Proposed methylation of aminooxetanes and rationale based on
cathinone.

The intermediates obtained through Mitsunobu reaction also can be easily
manipulated with a suitable nucleophile to diversify the construction of hetereocycles
other than oxetanes. As an example, azetidines can be obtained as demonstrated in the
prior literature (Tatibouet et al., 2001; Sajjadi et al., 2001).
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Scheme 69. Proposed synthesis of azetidine derivatives based on Mitsunobu
intermediates.

By providing a cheaper and shorter route to oxetin, the investigation of oxetin as
an amino acid surrogate in oligopeptides that carry serine, as an example, would be
feasible. The study of bradyoxetin on quorum sensing systems other than rhizobium, as
well as the study of bradyoxetin fragments on such pathways is worthy of pursuit.
Some of the challenges met in this dissertation research should be considered as
opportunities for future research. The regiocontrol of epoxide opening, stereocontroled
bromonium mediated reactions, and a comprehensive study on aromatic oxidative
degradation are ripe for study.
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CHAPTER 4: EXPERIMENTAL

4.1 General Methods

All commercially available starting materials and reagents were purchased
from Sigma-Aldrich (St. Louis, MO) unless otherwise noted. THF and diethyl ether were
distilled from sodium-benzophenone ketyl.

Analytical TLC plates (silica gel) were

purchased from Sorbent Technologies (G Series-UV 254).

Silica gel column

chromatography was conducted using standard chromatography grade silica gel, 20-63
µM particle size, (Sorbent Technologies). Analytical TLC plates (alumina-B F-254-200
micron plates) were purchased from Selecto Scientific. 1H NMR and

13

C NMR spectra

were recorded at either 400 or 500 MHz on a Bruker Avance DRX spectrometer. The 2D
NMR COSY, HMBC, HMQC, and NOESY were recorded at 500 MHz (Bruker Avance
DRX) or 600 MHz NMR (Varian). Elemental Analysis was obtained using a
PerkinElmer 2400 Series II CHNS/O Analyzer. Low-resolution mass spectrometry
analysis was performed using a Waters ZQ single-quadrupole system using either ESI
positive (ESI+) or ESI negative (ESI-) electrospray ionization. High-resolution mass
spectrometry (HRMS) was recorded using a Micromass Q-TOF micro instrument. HPLC
analysis was conducted with a Waters Delta Prep 4000 System with 7725I Rheodyne
injector and Water 2487 Dual Wavelength Absorbance Detector. FTIR were measured
using a Bruker Vector 33 system.

Optical rotations were obtained with a Rudolph

Autopol IV polarimeter at λ=589 nm.
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4.2 Synthetic Procedures and Compound Data
Ethyl (E)-4-iodo cinnamate (125). Ester 125 was prepared
O

from

4-iodobenzaldehyde

(123,

1.00

g,

mmol)

and

carbethoxymethylene triphenylphosphorane (124, 1.8 g,

O
125

I

mmol) in benzene, under reflux for 4 hours on a RBF. After the reaction was completed
the solvent was evaporated and the residue was purified using silica gel column
chromatography (95% hexanes-5% EtOAc) to yield 125 (90%). 1H NMR (400 MHz,
CDCl3): δ 7.70 (d, 2H, J = 8.5Hz), 7.57 (d, 1H, J = 16Hz), 7.23 (d, 2H, J = 8.5Hz), 6.42
(d, 1H, J = 16Hz), 4.25 (q, 2H, J = 7.1Hz), 1.33 (t, 3H, J = 7.1Hz).

(E)-3-(4-Iodophenyl) prop-2-en-1-ol (126).

A solution of

ethyl (E)-4-iodo cinnamate (125, 8.24 g, 27.2 mmol) in

OH
I

126

anhydrous CH2Cl2 (100 mL) was treated with i-Bu2AlH (82 mL, 1.0 M hexane solution,
82 mmol, 3.0 equiv) in three portions at -78oC , and the mixture was stirred at -78oC for
20 min. The reaction mixture was quenched by the addition of CH3OH (25 mL), warmed
to 25oC, diluted with saturated aqueous sodium potassium tartrate (100 mL), and
partitioned. The aqueous phase was extracted with CH2C12 (4 X 100 mL), and the
combined organic layers were washed with saturated aqueous sodium potassium tartrate
(150 mL), dried over Na2SO4, and concentrated in vacuo. Flash chromatography (silica
gel, 5 X 20 cm, 20-40% EtOAc-hexane) afforded 126 (7.07 g, 95%) as a white crystalline
solid: mp. 108-110 oC (1:2 EtOAc-hexane, white needles); 1H NMR (CDC13, 400 MHz)
δ 7.63 (d, 2H, J = 8.4 Hz, Ar C3- and C5-H), δ 7.10 (d, 2H, J = 8.4 Hz, Ar C2- and C6-
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H), δ 6.53 (d, 1H, J=15.8Hz, C3-H), 6.36 (dt, lH, J=5.4, 15.8 62.5 MHz)

13

C NMR

(CDC13, 101 MHz) δ 137.7, 136.2, 129.9, 129.4, 128.2, 92.9, 63.5; IR (neat) v-3310,
2926, 2847, 1651, 1478, 1395, 1084, 1060, 1006, 971, 848, 799, 774 cm-1.

(2S,3S)-2-(Hydroxymethyl)-3-(4-iodophenyl)oxirane

(127).

A solution of 126 (7.49 g, 26.0 mmol) in anhydrous CH2C12 (250

(S)

O
OH

( S)

I

127

mL) containing activated powdered 4-A molecular sieves (25 g, 1 g/mmol) was treated
sequentially with (+)-diisopropyl L-tartrate (457 mg, 1.9 mmol, 0.41 mL, 0.075 equiv)
and Ti(O-i-Pr)4 (314 mg, 1.30 mmol, 0.33 mL, 0.05 equiv) at -20oC (30 min). After
reagent aging was complete, t-BuOOH (3.5 M CH2Cl2 solution, 52.0 mmol, 14.9 mL, 2.0
equiv) was added dropwise (15 min). After 4 h, the mixture was warmed from -20 to 0 oC
(20 min), quenched by the addition of H2O (25 mL), and allowed to warm to 25oC (45
min). Aqueous NaOH (25%) (20 mL) was added and the mixture stirred at 25oC (45
min). Following the addition of CH3OH (10 mL), the aqueous phase was extracted with
CH2Cl2 (3 X 50 mt), dried (Na2SO4), and concentrated in vacuo. Flash chromatography
(SiO2, 20-50% EtOAc-hexane) afforded 127 (3.21 g, 45%) as a white solid. mp. 80-82
o

C. [α]25D -39.0 (c=1.0, MeOH).

1

H NMR (CDCl3, 400 MHz) δ 7.67 (d, 2H, J = 8 Hz,

Ar C3- and C5-H), 7.02 (d, 2H, J=8 Hz, Ar C2-and C6-H), 4.03 (ddd, 1H, J=2.0 12.9 Hz,
C1-H), 3.88 (d, 1H, J= 5.1 Hz, C3-H), 3.80 (ddd, 1H, J = 3.6, 7.6, 12.9 Hz, C1-H), 3.16
(m, 1H, C2-H), 1.85 (t, 1H, J = 6.2 Hz, OH);
136.53, 127.57, 93.72, 62.39, 61.00, 55.0.

89

13

C NMR (CDC13, 101 MHz) δ 137.63,

(2R,3R)-3-azido-3-(4-iodophenyl)propane-1,2-diol

(129).

N3
(R)

1786 mg of epoxide 126, NaN3 (4.14 g) and NH4Cl (1.53 g)
I

(R)

OH

OH

were dissolved in MeOH (12 ml) and water (2 ml) and heated to

129

112 oC, until the reaction was complete (the reaction was monitored using TLC). The
reaction mixture was evaporated and the residue was extracted with EtOAc. The phases
were separated and the aqueous phase was extracted with EtOAc. The combined organic
phases were washed with brine, dried over Na2SO4, concentrated and purified by silica
gel column chromatography (isocratic diethyl ether:petroleum ether) [9:1]. (Yellow oil,
yield 78%) [α]25D -187.20 (c=1.0, CHCl3). IR (CHCl3):ν 3385, 2930, 2104, 1647, 1587,
1541, 1485, 1400, 1249, 1040, 814, 453 cm-1. 1H NMR (CDCl3, 400 MHz) δ 7.73 (d, 2H,
J = 8 Hz, Ar C3- and C5-H), 7.08 (d, 2H, J=8 Hz, Ar C2-and C6-H), 4.52 (d, J = 6.8 Hz,
1H), 3.75 (s, 1H), 3.59 (m, 2H), 2.72 (s, 2H);

13

C NMR (CDCl3, 100 MHz): δ 62.84,

66.49, 73.88, 94.62, 129.68, 135.84, 138.08. ESIMS+; 342 (M++ 23), 661 (2M++ 23).

Reaction of tosyl derivative 130 with KOtBu

Potassium tert-butoxide (0.6 g) was

slowly added to a solution of the tosylate 130 (1.8 g) in anhydrous DCM at 0oC. The
reaction was monitored by TLC (70% diethyl ether: 30% petroleum ether). After
completion the reaction was quenched with water. The organic phase was extracted with
DCM and dried over Na2SO4. The organic phase was then separated and evaporated.
Purification of two product bands 131/132 (mixture) and 133 was accomplished using
silica gel chromatography (gradient of diethyl ether:petroleum ether [5:95to 50:50].
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[α]25D -

(R)-2-((R)-azido(4-iodophenyl)methyl)oxirane (133)

N3
( R)

132.20 (c=1.0, CHCl3). 1H NMR (CDCl3, 500 MHz): δ 7.76 (d, J =

( R)

I

133

8.5Hz, 2H), 7.13 (d, J = 8.5Hz, 2H), 4.57 (d, J = 4.5 Hz, 1H), 3.23–
3.21 (m, 1H), 2.88-2.85 (m, 1H);

13

O

C NMR (CDCl3, 101 MHz): δ 44.83, 53.61, 64.70,

94.62, 129.17, 135.53, 138.03. FTIR (CHCl3) ν 2103, 1647, 1587, 1541, 1486, 1398,
1296, 1061, 837, 452 cm-1; ESIMS (+): 301(MH+).

(Z)-3-azido-3-(4-iodophenyl)prop-2-en-1-ol

N3

N3
( E)

(132)

and

( Z)

(E)-3-azido-3-(4I

iodophenyl)prop-2-en-1-ol (131) (Major E

OH

+
I

131

OH
132

isomer listed).13C NMR (CDCl3, 100 MHz): 58.16, 95.20, 118.83, 128.74, 130.73,
133.85, 138.01.

Attempted synthesis of (2R,3S)-3-(4-iodophenyl)oxirane-2-

(S)

carboxylic acid (134)

O

O
OH

(R)

I

134

Method 1. To a vigorously stirred mixture of the epoxy alcohol 127 (276 mg, 1 mmol)
in 2 mL of carbon tetrachloride, 2 mL of acetonitrile, and 3 mL of water was added
sodium bicarbonate (0.42 g; 5 mmol), and sodium periodate (0.642 g ,3 mmol).
Ruthenium trichloride trihydrate (7.5 mg, 33 µmol) was then added. The mixture was
stirred at 20 oC for 44 h, after which the acidic material was extracted at 0 oC carefully
into diethyl ether and the organic layer dried over sodium sulfate. The ethereal fraction
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was submitted to acid-base work up. No oxidation product was detected by either ESI(-)MS or 13C-NMR analysis.
Method 2. Ruthenium trichloride trihydrate (0.0075 g, 33 µmol) was added to a stirring
biphasic mixture of epoxy alcohol 127 (0.15 g, 1 mmol), sodium periodate (0.642 g, 3
mmol), and sodium bicarbonate (0.42 g, 5 mmol) in CCl4 (2 mL), acetonitrile (2 mL), and
water (3 mL). After 42 h of stirring, an additional quantitity of RuCl3 (0.0076 g, 34 µmol)
and sodium periodate (0.157 g, 0.72 mmol) were added and the stirring was continued for
1 h to complete the reaction. Then, DCM (8 mL) was added followed by a small amount
of water (until phase separation occurred). The pH of the water layer was adjusted to 4.0
and the aqueous layer was extracted with DCM. Acidification and extraction were
repeated until the pH remained constant. The combined layer was dried over Na2SO4 and
solvent evaporated. No oxidation product was detected by either ESI(-)-MS or 13C-NMR
analysis.
Method 3 A solution of 127 (250 mg, 0.90 mmol) in anhydrous DMF (4.0 mL) was
treated with PDC (1.10 g, 2.87 mmol, 3.5 equiv) at 25 oC. After 5 h, additional PDC (348
mg, 0.90 mmol, 1.0 equiv) was added. The reaction mixture was stirred at 25 oC for an
additional 5 h before the addition of H2O (50 mL) and EtOAc (50 mL). The aqueous
phase was extracted with EtOAc (4 X 50 mL), and the combined organic layers were
washed successively with H2O (3 X 75 mL) and brine (3 X 75 mL). The organic layer
was dried over Na2SO4 and concentrated in vacuo. The crude residue was dissolved in
saturated aqueous NaHCO3 (10 mL) and EtOAc (10 mL). The organic phase was further
extracted with saturated aqueous NaHCO3 (3 X 10 mL), and the combined aqueous layers
were acidified to pH 4 with the addition of 5% aqueous HCl and extracted with EtOAc (4
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X 20 mL). The combined organic phase was washed with H2O (3 X 20 mL) and saturated
aqueous NaCl (3 X 20 mL), dried (Na2SO4), and concentrated in vacuo. No oxidation
product was detected by either ESI(-)-MS or 13C-NMR analysis.
Method 4. A stock solution of H5IO6/CrO3 was prepared by dissolving H5IO6 (11.4 g,
50 mmol) and CrO3 (23 mg, 1.2 mol %) in wet MeCN (0.75 v % water) to a volume of
114 mL (complete dissolution typically required 1-2 hours). The H5IO6/CrO3 solution
(11.4 ml) was then added to a solution of the alcohol 127 (2.0 mmol) in wet acetonitrile
(10 mL, 0.75 v % water) in 30-60 minutes while maintaining the reaction temperature at
0-5 °C. The mixture was aged at 0 °C for 0.5 h and the completion of the reaction was
confirmed by ESIMS. The reaction was quenched by adding an aqueous solution of
Na2HPO4, (0.60 g in 10 mL of H2O). Ethyl acetate was added and the organic phase was
submitted to acid-base work-up. The organic layer was separated and dried over Na2SO4.
No oxidation product was detected by either ESI(-)-MS or 13C-NMR analysis.

Bis(2,4,6-trimethylpyridine)silver(I) hexafluorophosphate (139).
A 2-L, three-necked, round-bottomed flask was equipped with a
mechanical stirrer and a 250-mL pressure-equalizing dropping funnel.

N
Ag+ PF6
N

The flask was charged with 1 L of distilled water, 100 g of silver nitrate

139

(0.588 mol) and 109.3 g of potassium hexafluorophosphate (0.594 mol)
When all the solids were dissolved, 221 mL of 2,4,6-collidine (1.67 mol) was added over
10 min with stirring. Technical grade 2,4,6-collidine can be used after purification by
distillation from calcium hydride CaH2. A slight exothermic reaction was observed,
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corresponding to the formation of a white solid. The mixture was stirred for 1 hr at room
temperature, the solid was suction filtered, and the filter cake was washed with 1 L of
water. The solid was dried in the dark in a desiccator under high vacuum over phosphorus
pentoxide (P2O5) for 1 week, to afford 262 g (90%) of the silver salt as a white-gray
solid, mp. 210°C.

Bis(2,4,6-trimethylpyridine)bromine(I) hexafluorophosphate (140).
A 1-L, three-necked, round-bottomed flask equipped with a mechanical
N

stirrer, a 50-mL pressure-equalizing addition funnel, and a drying tube

Br + PF6
N

containing calcium chloride was charged with 500 mL of dry DCM, and

140

82.5 g of bis(trimethylpyridine)silver(I) hexafluorophosphate (139,
0.166 mol). Then, 8.3 mL of bromine (0.161 mol) was added over a period of 10 min.
The mixture was stirred until all the bromine was consumed (1 hr) [Note: all of the
bromine should be consumed before removal of the solvent]. The resulting yellowish
solid (silver bromide) is suction filtered and washed with 100 mL of anydrous DCM. The
filtrate was concentrated on a rotary evaporator at a maximum bath temperature of 30°C
to give 65 g (83%) of bis(2,4,6-trimethylpyridine)bromine(I) hexafluorophosphate (140)
as a white solid (mp. 127-128°C). This solid must be stored in the dark at 0°C.
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O

3-bromo-2-(4-iodophenyl)oxetane (141). To bis(collidine)bromine(I)
hexafluorophosphate (140, 0.71 g, 1.5 mmol) in DCM (30 mL) was

Br

I

141

added a solution of allylic alcohol 126 (1.2 mmol) and 2,4,6-collidine

(0.15 g, 1.2 mmol) in DCM (10 mL) over 6 h. Subsequently, silica gel (2 g) was added
and the solvent was removed. The product was purified by flash chromatography over
silica gel using an initial gradient of petroleum ether 100% which was increased to
diethyl ether 20%-petroleum ether 80% affording oxetane 141 as an oil (6% yield) 1H
NMR: δ 3.92 (dd, J = 7.6 Hz, 1H); 4.26 (m, 1H), 4.47 (dd, 1H), 4.75 (d, 10 Hz, 1H), 7.72
(d, J = 8 Hz, 2H), 7.16 (d, J = 8 Hz, 2H). 13C NMR: δ 42.90, 76.34, 91.38, 94.60, 127.00,
137.88, 138.208.

(1R,2R)-2-amino-1-(4-nitrophenyl)propane-1,3-diol

(148).

OH
OH

Chloramphenicol (142) (3.0 g) was treated with 200 mL of 0.1
M aqueous NaOH at room temperature for 18 h. The solution

NH2

O2 N
148

was filtered and the white solid was washed with water and dried over P2O5 (high
vacuum) yielding hydrolysis product 148 (mp.161-162 oC): [α]25D -23.3o (c=3.0, MeOH).
Literature reported melting point and optical rotation are both in agreement with our
synthesized compound.

General procedure for diazotransfer reactions.
A typical experimental procedure for the preparation of triflyl azide was as follows: a
suspension of sodium azide (436 mg, 6.70 mmol) in 8 mL of acetonitrile (pyridine) was
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cooled in ice bath. Triflic anhydride (1.57 g, 5.56 mmol) was added by syringe at 0 oC
over a 5 minute period. The reaction was stirred for 2 h at 0 oC , and the TfN3- solution
(filtration of the salts can be done if necessary) was added directly to the amine solution
for the subsequent diazotransfer reaction.

General procedure for the reaction of triflic azide with amines. For organic soluble
substrates, 1.0 g of substrate was dissolved in 5 mL of acetonitrile (pyridine). In case of
saline substrates, water was employed. CuSO4 (1 mole %) and NEt3 (2 equilalents per
substrate amine) were added to the solution while stirring. The mixture was cooled in an
ice bath, followed the by the dropwise addition of an acetonitrile solution of triflyl azide
(1.2 equiv per amino group, based on the amount of triflic anhydride used in the
preparation of TfN3). The reaction mixture was allowed to warm to room temperature. A
homogeneous solution could be obtained after the addition of triflyl azide, and the
reaction normally is completed within 12 h. The reaction was monitored by TLC. After
its completion the solvent was removed by rotary evaporation and the crude product was
purified using silica gel chromatography. The purification proved to be difficult, mainly
due to the co-elution of a by-product derived from triflic anhydride. Multiple
purifications by column chromatography were performed in some instances.

(1R,2R)-2-azido-1-(4-nitrophenyl)propane-1,3-diol

OH

(149).

OH

Oil. IR (CHCl3): ν 3369, 2109, 1604, 1518, 1349, 1194, 1082,
O2N

857, 772, 702 cm-1. 1H NMR (400 MHz, CDCl3) δ 8.23 (d, J =
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N3
149

8.8 Hz, 2H), 7.60 (d, J = 8.8 Hz, 2H), 5.04 (d, J = 4.4 Hz, 1H), 3.59 (dd, J = 11.6, 4.0 Hz,
1H), 3.71 – 3.67 (m, 1H), 3.44 (dd, J = 9.2, 5.2 Hz, 1H), 2.65 (s, 1H), 2.15 (s, 1H). 13C
NMR (100 MHz, CDCl3) δ 147.55, 127.36, 123.83, 106.44, 73.73, 67.91, 62.76.
HRESI+MS: (C9H10N4O4Na) Calc: 261.0600. Found: 261.0587.

(1R,2R)-2-azido-1-(4-azidophenyl)propane-1,3-diol

(154).

OH

Oil. [α]25D -90.00 (c = 1.0, CHCl3); 1H NMR (400 MHz,
MeOD) δ 7.42 (d, J = 8.4 Hz, 2H), 7.06 (d, J = 8.5 Hz, 2H),

OH
N3

N3
154

4.73 (d, J = 6.0 Hz, 1H), 3.59 (dd, J = 11.0, 3.5 Hz, 1H), 3.55 – 3.48 (m, 1H), 3.44 (dd, J
= 11.0, 7.0 Hz, 1H), 2.65 (s, 1H), 2.15 (s, 1H). 13C NMR (100 MHz, MeOD) δ 140.93,
140.05, 129.30, 119.93, 74.15, 70.80, 62.95. HRESI-MS: (C9H10N6O2Na) Calc:
257.0763. Found: 257.0769.

(1S,2S)-2-azido-1-(4-azidophenyl)propane-1,3-diol (165).
Oil. [α]25D +87.00 (c = 1.0, CHCl3) 1H NMR (400 MHz,
MeOD) δ 7.42 (d, J = 8.4 Hz, 2H), 7.06 (d, J = 8.5 Hz, 2H),
4.73 (d, J = 6.0 Hz, 1H), 3.59 (dd, J = 11.0, 3.5 Hz, 1H), 3.55 – 3.48 (m, 1H), 3.44 (dd, J
= 11.0, 7.0 Hz, 1H), 2.65 (s, 1H), 2.15 (s, 1H). 13C NMR (100 MHz, MeOD) δ 140.93,
140.05, 129.30, 119.93, 74.15, 70.80, 62.95.
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(1R,2R)-1-(4-aminophenyl)-2-azidopropane-1,3-diol (152).

OH

Oil. [α]25D -66.00 (c = 1.0, CHCl3); 1H NMR (400 MHz,

OH
N3

H2N

152

MeOD) δ 7.13 (d, J = 8.4 Hz, 2H), 6.72 (d, J = 8.4 Hz, 2H),

4.84 (s, 1H), 4.53 (d, J = 7.2 Hz, 1H), 4.11 (q, J = 7.1 Hz, 1H), 3.76 (s, 2H), 3.74 – 3.41
(m, H), 3.41 – 3.18 (m, 23H), 2.02 (s, 21H), 1.24 (t, J = 7.1 Hz, 22H).

13

C NMR (101

MHz, MeOD) δ 148.62, 132.02, 128.57, 116.40, 74.90, 71.30, 63.11.

HRMS:

(C9H13N4O2) Calc: 209.1039. Found: 209.1039.

(1S,2S)-1-(4-aminophenyl)-2-azidopropane-1,3-diol (167).

OH

Oil. [α]25D +68.60 (c =1, CHCl3); 1H NMR (400 MHz, MeOD)
δ 7.13 (d, J = 8.3 Hz, 2H), 6.72 (d, J = 8.4 Hz, 2H), 4.53 (d, J

OH
N3

H2N
167

= 7.2 Hz, 1H), 4.11 (q, J = 7.1 Hz, 1H), 3.58 – 3.44 (m, 2H), 3.43 – 3.27 (m, 2H), 2.02 (s,
2H), 1.24 (t, J = 7.1 Hz, 2H). 13C NMR (100 MHz, MeOD) δ 148.60, 132.04, 128.57,
116.41, 74.90, 71.30, 63.11. HRMS: (C9H12N4O2Na) Calc: 231.0858. Found: 231.0853.

(1R,2R)-2-azido-1-phenylpropane-1,3-diol (187). Colorless oil.
[α]25D -80.40 (c =1, CHCl3); 1H NMR (400 MHz, MeOD) δ 7.40
(ddd, J = 14.5, 7.9, 4.2 Hz, 4H), 7.35 – 7.28 (m, 1H), 4.74 (d, J =
6.0 Hz, 1H), 3.64 – 3.54 (m, 2H), 3.48 (ddd, J = 20.8, 13.2, 7.7 Hz, 1H), 3.33 (s, 1H),
1.20 (t, J = 7.0 Hz, 1H). 13C NMR (100 MHz, MeOD) δ 142.95, 129.42, 128.92, 127.66,
74.80, 70.97, 63.01.
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(1S,2S)-2-azido-1-phenylpropane-1,3-diol

(191).

Oil.

[α]25D

+76.60 (c =1, CHCl3); 1H NMR (400 MHz, MeOD) δ 7.49 – 7.35
(m, 4H), 7.31 (t, J = 7.0 Hz, 1H), 4.74 (d, J = 6.0 Hz, 1H), 3.58 (dt, J
= 6.7, 3.6 Hz, 2H), 3.48 (ddd, J = 20.7, 13.2, 7.7 Hz, 1H), 3.33 (s, 1H). 13C NMR (101
MHz, MeOD) δ 142.96, 129.42, 128.92, 127.67, 74.81, 70.98, 63.02.

General procedure for modified Sandmeyer (bromination) reaction.
To a solution of aminoarene (5.0 mmol) in a mixture of 25 mL of DMSO and KNO2
(1.70 g, 20 mmol) was added dropwise a solution of 47% HBr (2.49 mL, 20 mmol) and
KI (4.15 g, 25 mmol) dissolved in DMSO (25 mL) at 35 °C. When the addition was
complete, the mixture was further stirred for an additional 10 min at 35 °C and then
transferred to a solution containing K2CO3 (5 g) in 100 mL ice water. The reaction
mixture was added to a volume of diethyl ether, and the ethereal extracts were washed
with water and dried over anhydrous magnesium sulfate. Removal of the solvent under
reduced pressure afforded the crude product.

General procedure for Sandmeyer (bromination) reaction.
An aqueous solution of NaNO2 (1.27 g, 18.85 mmol, 50 ml H2O) was added dropwise to
a solution of aminoarene (3.76 g, 16.8 mmol) in 35 ml of 48% aqueous HBr at 0 oC. After
addition was complete, the mixture was stirred for 30 min at 0 0C. The mixture was then
added dropwise to a solution of CuBr (2.65g, 18.45 mmol) in 15 ml 48% aqueous HBr.
The mixture was warmed to room temperature and stirred for additional 16 hours. The
reaction mixture was neutralized with 3 M aqueous NaOH, filtered through a pad of
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Celite, and extracted with EtOAc (3 x 100 mL). The combined organic fractions were
dried over anhydrous Na2SO4 and concentrated to give 1.2 g (4.17 mmol) of crude
product.
(1R,2R)-2-azido-1-(4-bromophenyl)propane-1,3-diol (155).

OH

Oil. [α]25D -74.50 (c =1, CHCl3); 1H NMR (400 MHz, d6acetone) δ 7.58 – 7.51 (m), 7.42 (d, J = 8.4 Hz), 4.92 (d, J = 4.4

OH
N3

Br
155

Hz), 4.24 (s), 3.75 (dd, J = 10.7, 3.3 Hz), 3.62 (d, J = 6.8 Hz), 3.57 (dd, J = 7.9, 3.2 Hz),
3.06 (s), 2.57 (s).

13

C NMR (100 MHz, d6-acetone) δ 141.84, 131.11, 128.65, 120.81,

72.69, 69.00, 61.82. HRESI+MS: (C9H10BrN3O2Na) Calc: 293.9854. Found: 293.9860.

(1R,2R)-2-azido-1-(4-bromophenyl)propane-1,3-diol

(168).

OH

Oil. [α]25D +78.00 (c =1, CHCl3); 1H NMR (400 MHz, d6acetone) δ 7.58 – 7.51 (m), 7.42 (d, J = 8.4 Hz), 4.92 (d, J = 4.4

OH
N3

Br
168

Hz), 4.24 (s), 3.75 (dd, J = 10.7, 3.3 Hz), 3.62 (d, J = 6.8 Hz), 3.57 (dd, J = 7.9, 3.2 Hz),
3.06 (s), 2.57 (s).

13

C NMR (100 MHz, d6-acetone) δ 141.84, 131.11, 128.65, 120.81,

72.69, 69.00, 61.82.

General procedure for Sandmeyer (cyanation) reaction.
To the aminoarene (10.26 g, 49 mmol) was added concentrated HCl (26 mL) and H2O
(130 mL) at room temperature, and then cooled to 0oC. The resulting suspension was
diazotized at 0 to 5 oC with NaNO2 (3.7 g, 53 mmol) in H2O (20 mL). After stirring for
30 minutes at 0 oC, the mixture was added to a solution of CuCN (9.23 g, 0.085 mol) and
KCN (16.6g, 0.255 mol) in H2O (80 mL). The mixture was vigorously stirred at 0 oC for
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1 hour and then warmed to 50 oC. After cooling, the mixture was extracted with EtOAc.
The organic phase was washed with 1 M NaOH (90 mL), H2O (90 mL), dried over
Na2SO4 and evaporated. Silica gel column chromatography (EtOAc:hexanes 1:1) yielded
the nitrile product.

4-((1R,2R)-2-azido-1,3-dihydroxypropyl)benzonitrile (157).

OH

Oil. [α]25D -39.59 (c =0.5, CHCl3); 1H NMR (400 MHz, d6-

OH
N3

NC

acetone) δ 7.78 (d, J = 8.3 Hz), 7.68 (d, J = 8.2 Hz), 5.13 (d, J =

157

4.7 Hz), 3.85 – 3.78 (m), 3.63 (ddt, J = 11.0, 6.7, 5.5 Hz), 3.13 (s). 13C NMR (100 MHz,
d6-acetone) δ 147.97, 131.93, 127.52, 118.50, 111.13, 72.72, 68.59, 61.81.

General Experimental Procedure for the Tosylation of 1,3-diols.
To a solution of diol (10 mmol) in DCM (20 mL) was added Bu2SnO (0.2 mmol), pTsCl (10 mmol), and Et3N (10 mmol). The reaction mixture was stirred until TLC
indicated complete consumption of the starting material (8-12 hours). The mixture was
filtered, and the filtrate was concentrated in vacuo. The residue was crystallized or
purified using silica gel chromatography to afford the desired monotosylate.

(2R,3R)-2-azido-3-(4-bromophenyl)-3 hydroxypropyl 4-

OH
O

methylbenzenesulfonate (158). Oil. [α]25D -35.80 (c =1,
Br
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N3
158

Ts

CHCl3); 1H NMR (400 MHz, d6-acetone) δ 7.78 (d, J = 8.2 Hz, 1H), 7.49 (dd, J = 8.1, 5.3
Hz, 2H), 7.40 (d, J = 8.5 Hz, 1H), 7.34 (dd, J = 8.4, 4.3 Hz, 1H), 5.20 (dd, J = 4.6, 3.1
Hz, 1H), 4.91 (dd, J = 10.9, 5.5 Hz, 1H), 4.17 (dd, J = 10.4, 3.2 Hz, 1H), 3.98 – 3.90 (m,
1H), 3.89 – 3.82 (m, 1H), 3.40 (q, J = 7.0 Hz, 1H), 2.91 (s, 2H), 2.88 (s, 1H), 2.47 (s,
2H).

(2R,3R)-2-azido-3-(4-cyanophenyl)-3-hydroxypropyl

4-

OH

methylbenzenesulfonate (160). Oil. 1H NMR (400 MHz, d6acetone) δ 7.82 (d, J = 8.2 Hz), 7.72 (d, J = 8.2 Hz), 7.63 (d, J

O
NC

Ts

N3
160

= 8.2 Hz), 7.47 (d, J = 8.1 Hz), 5.32 (d, J = 4.8 Hz), 4.30 (dd, J = 10.5, 3.5 Hz), 4.07 (dd,
J = 10.4, 7.5 Hz), 3.99 – 3.93 (m), 2.46 (s).

13

C NMR (101 MHz, d6-acetone) 146.54,

145.51, 132.61, 132.18, 130.17, 127.95, 127.51, 118.50, 111.57, 72.50, 69.30, 65.34,
20.89.

(2R,3R)-2-azido-3-(4-azidophenyl)-3-hydroxypropyl

4-

methylbenzenesulfonate (162). Oil. [α]25D -60.59 (c =1,
CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.76 (d, J = 8.3 Hz,
1H), 7.35 (d, J = 8.1 Hz, 1H), 7.30 (d, J = 8.4 Hz, 1H), 7.00 (d, J = 8.5 Hz, 1H), 4.75 (d,
J = 5.6 Hz, 1H), 4.16 – 4.09 (m, 1H), 3.91 (dd, J = 10.5, 6.7 Hz, 1H), 3.72 (td, J = 6.3,
4.4 Hz, 1H), 2.65 (s, 1H), 2.46 (s, 2H), 2.03 (s, 1H). 13C NMR (100 MHz, CDCl3) δ
145.51, 140.55, 136.07, 132.35, 130.12, 128.09, 127.91, 119.47, 72.83, 68.64, 65.74,
21.79.
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Attempted Synthesis of 152 by Selective Reduction of Nitro Aromatic 149
Method 1. The nitro derivative 149 (200 mg) was dissolved in THF (10 mL) and water
(4 mL) was added. To this stirring mixture was added sodium dithionite (310 mg), and
this was stirred at room temperature for 2 h. The solution was warmed to 40oC for 10 min
and then allowed to cool to room temperature. Another portion of sodium dithionite (150
mg) was added and stirring was continued for another 3 h. The reaction was monitored by
TLC (acetone: chloroform; 1:1). After the reaction was complete, the solvent was
evaporated and the residue purified by silica gel column chromatography. The product
was isolated but contained significant contaminants.
Method 2. An aqueous solution (20 ml) containing K2CO3 (4.15 g, 30 mL) and Na2S2O4
(4.70 g, 27 mmol) was added dropwise to a mixture of nitroarene 149 (6 mmol) and
viologen (0.162 g, 0.3 mmol) in DCM (40 mL) and water (5 mL) under an inert
atmosphere of argon. Stirring was continued for 2-8 h at 35oC and then the aqueous layer
was extracted with DCM (3 X 20 mL). The combined organic layers were dried, and
treated with silica gel to remove any remaining viologen species. TLC analysis showed
the same profile when compared to the reaction performed with Na2S2O4.
Method 3. The nitro derivative 149 (238 mg, 1mmol) was treated with 606 mg of Na2S
in absolute EtOH. The reaction was monitored by TLC and presented the same profile on
the other two previous methodologies, but appeared to contain less side products.

(1R,2S)-2-amino-1-(4-aminophenyl)propane-1,3-diol

(153).
OH

A 2 l round bottom flask was charged with 47.86 g of compound
OH
NH2

H2 N
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153

148, absolute ethanol and 7.17 g of Pd/C. After stirring for 5 minutes, vacuum was
applied to the round bottom flask and a volume of hydrogen gas was introduced. The
reaction was stirred at room temperature and monitored with TLC. The reduction was
complete after 4 days. The reaction was filtered and the Pd/C recovered. The ethanol was
evaporated and the residue recrystallized from ethanol to afford 153 in 90% yield.
Procedures for the synthesis of oxetanes.
Method 1. (K-tert-butoxide). 3.21g of tosylated precursor was dissolved in anhydrous
THF (75 mL) and anhydrous benzene (75 mL). Potassium tert-butoxide (1.26 g) was
added, and the mixture brought to reflux. Complete consumption of starting material was
evident after an excess of base was added (1.5 additional equivalents). After cooling to
room temperature, the reaction mixture was quenched with water and extracted with
EtOAc, dried over sodium sulfate and evaporated. The crude residue was purified by
silica gel chromatography [hexane:EtOAc gradient (100:0 to 60:40)] and homogenous
product bands characterized.
Method 2 (Potassium carbonate) To a solution of tosylated precursor (130 mg) in
MeOH (20 mL) was added K2CO3 (52 mg) at 0 °C and allowed to warm to room
temperature.

This stirred for 5 days with TLC monitoring. After completion, the

methanol was removed under reduced pressure and the residue was purified using silica
gel column chromatography. Yield of oxetane products ranged from 70-90%.

(2R,3R)-3-azido-2-(4-nitrophenyl)oxetane (151). Oil. [α]25D -

O

68.38 (c =1, CHCl3); 1H NMR (400 MHz, d6-acetone) δ 8.25 (d, J =
O2 N
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N3
151

9.0 Hz, 2H), 7.75 (d, J = 9.0 Hz, 1H), 5.49 (d, J = 4.7 Hz, 1H), 5.13 (t, J = 4.6 Hz, 1H),
3.83 (m, 1H), 3.63 (dd, J = 13.0, 4.1 Hz, 1H), 3.46 (dd, J = 13.0, 7.9 Hz, 1H). 13C NMR
(100 MHz, d6-acetone) δ 150.15, 128.62, 124.18, 100.88, 73.99, 67.35, 52.40.

(2R,3R)-3-azido-2-(4-bromophenyl)oxetane (159). Oil. [α]25D -

O

23.10 (c =1, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.57 (d, J = 8.3

N3
159

Br

Hz, 2H), 7.30 (d, J = 8.3 Hz, 2H), 5.90 (d, J = 6.6 Hz, 1H), 4.99 (t, J

= 7.0 Hz, 1H), 4.77 (dd, J = 12.1, 6.2 Hz, 1H), 4.60 – 4.52 (m, 1H). 13C NMR (101 MHz,
CDCl3) δ 135.80, 131.64, 128.03, 122.56, 86.07, 74.10, 57.97.

(2R,3S)-3-azido-2-(4-bromophenyl)oxetane (175). Oil. [α]25D +13.79

O

(c =1, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.54 (d, J = 8.4 Hz, 2H),

N3
175

Br

7.30 (d, J = 8.3 Hz, 2H), 5.57 (d, J = 6.0 Hz, 1H), 4.76 (t, J = 7.1 Hz,
1H), 4.63 (t, J = 6.8 Hz, 1H), 4.28 (dd, J = 13.5, 6.8 Hz, 1H).

13

C NMR (101 MHz,

CDCl3) δ 138.63, 131.95, 126.95, 122.66, 88.04, 72.72, 61.56.

4-((2R,3R)-3-azidooxetan-2-yl)benzonitrile (161). Oil. [α]25D -

O

24.10 (c =1, CHCl3); 1H NMR (400 MHz, d6-acetone) δ 7.84 (d, J =
N3

NC

8.3 Hz, 1H), 7.66 (d, J = 8.0 Hz, 1H), 6.11 (d, J = 6.7 Hz, 1H), 5.10

161

(dd, J = 11.7, 6.7 Hz, 1H), 5.02 (t, J = 7.0 Hz, 1H), 4.50 (dd, J = 6.6, 5.0 Hz, 1H). 13C
NMR (101 MHz, d6-acetone) δ 148.64, 147.60, 132.83, 128.34, 119.27, 112.08, 100.15,
73.90.
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4-((2S,3S)-3-azidooxetan-2-yl)benzonitrile (173). Oil. [α]25D +25.20

O

(c =1, CHCl3); 1H NMR (400 MHz, d6-acetone) δ 7.84 (d, J = 8.3 Hz,

N3

NC
173

1H), 7.66 (d, J = 8.0 Hz, 1H), 6.11 (d, J = 6.7 Hz, 1H), 5.10 (dd, J =

11.7, 6.7 Hz, 1H), 5.02 (t, J = 7.0 Hz, 1H), 4.50 (dd, J = 6.6, 5.0 Hz, 1H). 13C NMR (101
MHz, d6-acetone) δ 148.64, 147.60, 132.83, 128.34, 119.27, 112.08, 100.15, 73.90.

4-((2R,3S)-3-azidooxetan-2-yl)benzonitrile (177). Oil. [α]25D +19.80

O

(c =1, CHCl3); 1H NMR (400 MHz, d6-acetone) δ 7.85 (d, J = 8.3 Hz,

N3

NC
177

2H), 7.69 (d, J = 8.2 Hz, 2H), 5.70 (d, J = 5.5 Hz, 1H), 4.90 – 4.82 (m,
1H), 4.65 – 4.57 (m, 2H).

13

C NMR (101 MHz, d6-acetone) δ 148.64, 147.60, 132.83,

128.34, 119.27, 112.08, 100.15, 73.90.

(2R,3R)-3-azido-2-(4-azidophenyl)oxetane (163). Oil. [α]25D -

O

30.39 (c =1, CHCl3);1H NMR (400 MHz, CDCl3) δ 7.41 (d, J = 8.4
N3

Hz, 2H), 7.09 (d, J = 8.4 Hz, 2H), 5.91 (d, J = 6.6 Hz, 1H), 4.96 (t, J

N3
163

= 7.0 Hz, 1H), 4.75 (dd, J = 11.9, 6.5 Hz, 1H), 4.53 (dd, J = 7.1, 5.2 Hz, 1H). 13C NMR
(100 MHz, CDCl3) δ 140.17, 133.41, 127.92, 118.98, 86.07, 73.88, 58.11.

(2S,3S)-3-azido-2-(4-bromophenyl)oxetane

(170).

Oil.

[α]25D

O

+22.00 (c =1, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.57 (d, J = 8.3
Br

Hz, 2H), 7.30 (d, J = 8.3 Hz, 2H), 5.90 (d, J = 6.6 Hz, 1H), 4.99 (t, J
= 7.0 Hz, 1H), 4.77 (dd, J = 12.1, 6.2 Hz, 1H), 4.60 – 4.52 (m, 1H).
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N3
170

(2R,3R)-3-azido-2-phenyloxetane (179). Oil. [α]25D -38.40 (c =1,
CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.51 – 7.35 (m, 3H), 5.97
(d, J = 6.7 Hz, 1H), 5.00 (t, J = 7.0 Hz, 1H), 4.78 (dd, J = 11.9, 6.7 Hz, 1H), 4.59 (dd, J =
6.9, 5.5 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 136.74, 128.50, 128.45, 126.31, 86.65,
73.96, 58.04.

(2S,3R)-3-azido-2-phenyloxetane (190). Oil. [α]25D 7.2 (c =1,
CHCl3); 1H NMR (400 MHz, d6-acetone)) δ 7.50 (dd, J = 8.0, 1.1 Hz,
2H), 7.44 (t, J = 7.4 Hz, 2H), 7.37 (ddd, J = 8.2, 2.6, 1.3 Hz, 1H), 5.59 (d, J = 5.7 Hz,
1H), 4.79 (t, J = 6.6 Hz, 1H), 4.64 – 4.46 (m, 2H).

13

C NMR (101 MHz, MeOD) δ

139.76, 128.46 (x2C), 125.30, 88.81, 72.41, 61.46.

(2S,3S)-3-azido-2-phenyloxetane (193). Oil. [α]25D +51.20 (c =1,
CHCl3); 1H NMR (400 MHz, d6-acetone)) δ 7.62 – 7.26 (m, 6H),
6.02 (d, J = 5.9 Hz, 1H), 5.08 – 4.89 (m, 2H), 4.58 – 4.40 (m, 1H). 13C NMR (100 MHz,
d6-acetone)) δ 138.76, 129.06, 128.94, 127.31, 87.12, 74.30, 59.38.

(2R,3S)-3-azido-2-phenyloxetane (195). Oil. [α]25D -6.4 (c =1,
CHCl3); 1H NMR (400 MHz, d6-acetone)) δ 7.49 (dd, J = 8.0, 1.1 Hz,
2H), 7.43 (t, J = 7.4 Hz, 2H), 7.36 (ddd, J = 8.2, 2.6, 1.3 Hz, 1H), 5.58 (d, J = 5.7 Hz,
1H), 4.86 – 4.73 (m, 1H), 4.62 – 4.46 (m, 2H).

13

141.11, 129.45, 129.34, 126.41, 89.08, 73.08, 62.28.
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C NMR (100 MHz, d6-acetone)) δ

4-((2R,3R)-3-aminooxetan-2-yl)benzonitrile (196). Oil. 1H NMR

O

(400 MHz, MeOD) δ 7.82 (d, J = 8.3 Hz, 2H), 7.58 (d, J = 8.0 Hz,
NC

3H), 5.94 (d, J = 6.8 Hz, 1H), 5.08 – 4.97 (m, 1H), 4.46 – 4.34 (m,
2H).

13

NH2
196

C NMR (101 MHz, MeOD) δ 145.14, 133.38, 128.12, 119.76, 112.43, 89.15,

79.63, 51.66.

Attempted Grignard reactions of 159 with magnesium. A solution of (2R,3R)-3azido-2-(4-bromophenyl)oxetane 159 (50 mg, 0.197 mmol) in anhydrous THF (10 mL)
was added dropwise to magnesium turnings (5.91 mg) in anhydrous THF (20 mL) under
an atmosphere of argon. A crystal of iodine was necessary to initiate the Grignard
reaction. The reaction was refluxed for 2 h. The solvent was removed from the reaction
mixture by rotary evaporation, and a solution of 161 (30 mg, 0.150 mmol) in anhydrous
toluene (30 mL) was added slowly. The reaction mixture was refluxed for 12 h. An
aliquot was taken from the reaction medium and quenched with NH4Cl, to observe the
formation of (2R,3R)-3-azido-2-phenyloxetane (178) by LC-MS. Only starting material
remained.

Attempted Grignard reactions of 159 with iPrMgCl-LiCl.
Preparation of the reagent i-PrMgCl·LiCl: Magnesium turnings (110 mmol) and
anhydrous LiCl (100 mmol) were placed in an Ar-flushed flask, and anhydrous THF (50
mL) was added. A solution of iPrCl (100 mmol) in THF (50 mL) was slowly added at
room temperature. The reaction started within a few minutes. After the addition, the
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reaction mixture was stirred for 12 h at room temperature. The gray solution of
iPrMgCl·LiCl was cannulated into another Ar-filled flask leaving behind excess Mg
metal.

Reaction with arylbromide 159.

A flame-dried argon-flushed 10 mL flask,

equipped with a magnetic stirrer and a septum, was charged with a solution of 159 (50
mg) in anhydrous THF (0.2 mL). i-PrMgCl.LiCl (2.0 M/THF, 0.2 mmol, 1.1 equiv) was
added slowly at -40 °C, and the resulting mixture was stirred at this temperature for 12 h
to complete the bromine-magnesium exchange (checked by reaction of aliquots with
NH4Cl). Nitrile 161 (50 mg in 2 mL of THF, 1.1 equiv) was added. The mixture was
warmed to room temperature and stirred for 12 hours. This was quenched with saturated
aqueous NH4Cl. Although the Mg insertion was confirmed, no product was observed
with the addition of the benzonitrile.

(1R,2R)-1-(4-acetamidophenyl)-2-azidopropane-1,3-diyl
diacetate (182). Oil. 1H NMR (400 MHz, MeOD) δ 7.59 (d, J
= 8.5 Hz, 1H), 7.35 (d, J = 8.5 Hz, 1H), 5.81 (d, J = 7.3 Hz,
1H), 4.10 (dq, J = 5.4, 3.7 Hz, 1H), 3.84 (td, J = 7.5, 1.9 Hz, 1H), 2.12 (s, 1H), 2.10 (s,
2H), 2.04 (s, 1H).

13

C NMR (100 MHz, MeOD) δ 170.59, 170.32, 169.89, 139.13,

131.97, 127.38, 119.77, 74.98, 63.57, 62.89, 22.48, 19.47, 19.11.

General Methodology for Misunobu Reactions. Diisopropylazodicarboxylate (DIAD)
(0.07 mL, 0.45 mmol) was added to a solution of Ph3P (75 mg, 0.45 mmol) in anhydrous
THF (5 mL) at 0oC under an inert atmosphere of argon. The solution was stirred for 15
minutes. A solution of the tosylated alcohol in THF (5 mL) was added dropwise. The
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resulting bright yellow solution was stirred for 15 min at 0 °C and then 4 h at room
temperature. The reaction was monitored by TLC. The solvent was removed, and the
residue purified by silica gel column chromatography with hexanes:EtOAc (97:3).

(1R,2S)-2-azido-1-(4-bromophenyl)-3-(tosyloxy)propyl

4-

nitrobenzoate (174). [α]25D 5.0 (c =1, CHCl3); 1H NMR (400
MHz, d6-acetone) δ 8.45 – 8.34 (m, 4H), 8.30 (d, J = 8.9 Hz,
2H), 7.78 (d, J = 8.3 Hz, 2H), 7.67 – 7.56 (m, 4H), 7.56 – 7.46
(m, 3H), 7.42 (d, J = 8.1 Hz, 2H), 6.11 (d, J = 6.7 Hz, 1H),
4.61 – 4.49 (m, 2H), 4.45 – 4.34 (m, 2H), 4.33 – 4.21 (m, 2H), 2.40 (s, 3H).

13

C NMR

(100 MHz, d6-acetone) δ 162.86, 151.09, 145.41, 135.36, 134.70, 131.75, 131.00, 130.04,
129.48, 129.42, 127.85, 123.70 , 122.61, 74.50, 68.10, 62.91, 20.58.

(1S,2R)-2-azido-1-phenyl-3-(tosyloxy)propyl

4-nitrobenzoate
NO2

(189). [α]25D -9.57 (c = 1.0, CHCl3) IR (CHCl3,) ν 2117, 1734, 1600,
1530, 1267, 1178, 1099. 1H NMR (400 MHz, CDCl3) δ 8.22 (dd, J =
O

O

28.9, 8.9 Hz, 4H), 7.76 (d, J = 8.3 Hz, 2H), 7.36 (ddd, J = 24.5, 13.7,
OTs

5.8 Hz, 8H), 6.08 (d, J = 6.0 Hz, 1H), 4.23 (td, J = 6.3, 4.4 Hz, 1H),

N3

189

4.17 (dd, J = 10.5, 4.3 Hz, 1H), 4.15 – 4.08 (m, 1H), 2.40 (s, 3H). 13C NMR (100 MHz,
CDCl3) δ 163.08, 150.78, 145.50, 134.82, 132.14, 130.95, 130.05, 129.41, 128.94,
127.98, 127.18, 126.49, 123.63, 75.57, 67.63, 63.11, 21.02.
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(1R,2S)-2-azido-1-phenyl-3-(tosyloxy)propyl

4-nitrobenzoate

NO2

(194). [α]25D +12.65 (c = 1.0, CHCl3) IR (CHCl3,) ν 2117, 1734,
1600, 1530, 1267, 1178, 1099. 1H NMR (400 MHz, CDCl3) δ 8.22
O

O

(dd, J = 28.9, 8.9 Hz, 4H), 7.76 (d, J = 8.3 Hz, 2H), 7.36 (ddd, J =

OTs
N3

24.5, 13.7, 5.8 Hz, 8H), 6.08 (d, J = 6.0 Hz, 1H), 4.23 (td, J = 6.3,

194

4.4 Hz, 1H), 4.17 (dd, J = 10.5, 4.3 Hz, 1H), 4.15 – 4.08 (m, 1H), 2.40 (s, 3H). 13C NMR
(100 MHz, CDCl3) δ 163.08, 150.8, 145.50, 134.82, 132.14, 130.95, 130.05, 129.41,
128.94, 127.98, 127.18, 126.49, 123.63, 75.57, 67.63, 63.11, 21.02.

(1R,2S)-2-azido-1-(4-cyanophenyl)-3-(tosyloxy)propyl 4-

NO2

nitrobenzoate (176). [α]25D +34.59 (c = 1.0, CHCl3); 1H
NMR (400 MHz, , d6-acetone) δ 8.35 (dd, J = 20.3, 9.0 Hz,
O

O

4H), 7.80 (dd, J = 14.4, 8.2 Hz, 6H), 7.42 (d, J = 8.0 Hz,
2H), 6.20 (d, J = 6.7 Hz, 1H), 4.61 (td, J = 6.5, 3.5 Hz, 1H),

O
NC

Ts

N3
176

4.42 (dd, J = 10.9, 3.5 Hz, 1H), 4.31 (dd, J = 10.9, 6.3 Hz, 1H), 2.41 (s, 3H). 13C NMR
(101 MHz, Acetone) δ 162.90, 159.52, 156.35, 156.31, 145.47, 141.17, 134.45, 132.56,
131.07, 130.07, 128.37, 127.86, 123.67, 112.80, 74.46, 68.31, 62.82, 21.34.
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